<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Parenteral fluid regimens for improving functional outcome in people with acute stroke - Visvanathan, A - 2015 | Cochrane Library</title> <meta content="Parenteral fluid regimens for improving functional outcome in people with acute stroke - Visvanathan, A - 2015 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011138.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Parenteral fluid regimens for improving functional outcome in people with acute stroke - Visvanathan, A - 2015 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011138.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011138.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Parenteral fluid regimens for improving functional outcome in people with acute stroke" name="citation_title"/> <meta content="Akila Visvanathan" name="citation_author"/> <meta content="NHS Lothian" name="citation_author_institution"/> <meta content="akila232@hotmail.com" name="citation_author_email"/> <meta content="Martin Dennis" name="citation_author"/> <meta content="University of Edinburgh" name="citation_author_institution"/> <meta content="William Whiteley" name="citation_author"/> <meta content="University of Edinburgh" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="9" name="citation_issue"/> <meta content="10.1002/14651858.CD011138.pub2" name="citation_doi"/> <meta content="2015" name="citation_date"/> <meta content="2015/09/01" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011138.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011138.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011138.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Stroke Rehabilitation; Colloids [administration &amp; dosage, adverse effects]; Crystalloid Solutions; Fluid Therapy [adverse effects, *methods, mortality]; Isotonic Solutions [*administration &amp; dosage, adverse effects]; Rehydration Solutions [*administration &amp; dosage, adverse effects]; Stroke [mortality]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011138.pub2&amp;doi=10.1002/14651858.CD011138.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011138.pub2&amp;doi=10.1002/14651858.CD011138.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011138.pub2&amp;doi=10.1002/14651858.CD011138.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011138.pub2&amp;doi=10.1002/14651858.CD011138.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011138.pub2&amp;doi=10.1002/14651858.CD011138.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011138.pub2&amp;doi=10.1002/14651858.CD011138.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011138.pub2&amp;doi=10.1002/14651858.CD011138.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011138.pub2&amp;doi=10.1002/14651858.CD011138.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011138.pub2&amp;doi=10.1002/14651858.CD011138.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011138.pub2&amp;doi=10.1002/14651858.CD011138.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011138.pub2&amp;doi=10.1002/14651858.CD011138.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011138.pub2&amp;doi=10.1002/14651858.CD011138.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011138.pub2&amp;doi=10.1002/14651858.CD011138.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011138.pub2&amp;doi=10.1002/14651858.CD011138.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011138.pub2&amp;doi=10.1002/14651858.CD011138.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011138.pub2&amp;doi=10.1002/14651858.CD011138.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011138.pub2&amp;doi=10.1002/14651858.CD011138.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011138.pub2&amp;doi=10.1002/14651858.CD011138.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011138.pub2&amp;doi=10.1002/14651858.CD011138.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011138.pub2&amp;doi=10.1002/14651858.CD011138.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011138.pub2&amp;doi=10.1002/14651858.CD011138.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011138.pub2&amp;doi=10.1002/14651858.CD011138.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011138.pub2&amp;doi=10.1002/14651858.CD011138.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="mV7VuqgF";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011138\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011138\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011138\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011138\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","hr","fr","fa"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011138.pub2",title:"Parenteral fluid regimens for improving functional outcome in people with acute stroke",firstPublishedDate:"Sep 1, 2015 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Stroke Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=mV7VuqgF&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011138.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011138.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011138.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011138.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011138.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011138.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011138.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011138.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011138.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011138.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>2240 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011138.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011138.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011138.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011138.pub2/full#CD011138-abs-0004"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011138.pub2/full#CD011138-sec-0079"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011138.pub2/full#CD011138-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011138.pub2/full#CD011138-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011138.pub2/full#CD011138-sec-0032"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011138.pub2/full#CD011138-sec-0033"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011138.pub2/full#CD011138-sec-0056"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011138.pub2/full#CD011138-sec-0073"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011138.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011138.pub2/appendices#CD011138-sec-0084"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011138.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011138.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/table_n/CD011138StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/table_n/CD011138StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011138.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011138.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011138.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011138.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011138.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011138.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2015 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Parenteral fluid regimens for improving functional outcome in people with acute stroke</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011138.pub2/information#CD011138-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Akila Visvanathan</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011138.pub2/information#CD011138-cr-0003">Martin Dennis</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011138.pub2/information#CD011138-cr-0004">William Whiteley</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/information/en#CD011138-sec-0091">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 01 September 2015 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011138.pub2">https://doi.org/10.1002/14651858.CD011138.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011138-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011138-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011138-abs-0003">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011138-abs-0008">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011138-abs-0002">Français</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011138-abs-0001" lang="en"> <section id="CD011138-sec-0001"> <h3 class="title" id="CD011138-sec-0001">Background</h3> <p>Parenteral fluids are commonly used in people with acute stroke with poor oral fluid intake. However, the balance between benefit and harm for different fluid regimens is unclear. </p> </section> <section id="CD011138-sec-0002"> <h3 class="title" id="CD011138-sec-0002">Objectives</h3> <p>To assess whether different parenteral fluid regimens lead to differences in death, or death or dependence, after stroke based on fluid type, fluid volume, duration of fluid administration, and mode of delivery. </p> </section> <section id="CD011138-sec-0003"> <h3 class="title" id="CD011138-sec-0003">Search methods</h3> <p>We searched the Cochrane Stroke Group Trials Register (May 2015), the Cochrane Central Register of Controlled Trials (CENTRAL), the Cochrane Database of Systematic Reviews (CDSR) and the Database of Abstracts of Reviews of Effects (DARE) (Cochrane Library 2015, Issue 5), MEDLINE (2008 to May 2015), EMBASE (2008 to May 2015), and CINAHL (1982 to May 2015). We also searched ongoing trials registers (May 2015) and reference lists, performed cited reference searches, and contacted authors. </p> </section> <section id="CD011138-sec-0004"> <h3 class="title" id="CD011138-sec-0004">Selection criteria</h3> <p>Randomised trials of parenteral fluid regimens in adults with ischaemic or haemorrhagic stroke within seven days of stroke onset that reported death or dependence. </p> </section> <section id="CD011138-sec-0005"> <h3 class="title" id="CD011138-sec-0005">Data collection and analysis</h3> <p>One review author screened titles and abstracts. We obtained the full‐text articles of relevant studies, and two review authors independently selected trials for inclusion and extracted data. We used Cochrane's tool for bias assessment. </p> </section> <section id="CD011138-sec-0006"> <h3 class="title" id="CD011138-sec-0006">Main results</h3> <p>We included 12 studies (2351 participants: range 27 to 841).</p> <p>Characteristics: The 12 included studies compared hypertonic (colloids) with isotonic fluids (crystalloids); of these, five studies (1420 participants) also compared 0.9% saline with another fluid. No data were available to make other comparisons. Delay from stroke to recruitment varied from less than 24 hours to 72 hours. Duration of fluid delivery was between two hours and 10 days. </p> <p>Bias assessment: Investigators and participants in eight of the 12 included studies were blind to treatment allocation, seven of the 12 included studies gave details of randomisation, and eight of the 12 included studies reported all outcomes measured. </p> <p>Results: There were no relevant completed trials that addressed the effect of volume, duration, or mode of fluid delivery on death or dependence in people with stroke. </p> <p>The odds of death or dependence were similar in participants allocated to colloids or crystalloid fluid regimens (odds ratio (OR) 0.97, 95% confidence interval (CI) 0.79 to 1.21, five studies, I² = 58%, low‐quality evidence), and between 0.9% saline or other fluid regimens (OR 1.04, 95% CI 0.82 to 1.32, three studies, I² = 71%, low‐quality evidence). There was substantial heterogeneity in these estimates. </p> <p>The odds of death were similar between colloids and crystalloids (OR 1.02, 95% CI 0.82 to 1.27, 12 studies, I² = 24%, moderate‐quality evidence), and 0.9% saline and other fluids (OR 0.87, 95% CI 0.67 to 1.12, five studies, I² = 53%, low‐quality evidence). The odds of pulmonary oedema were higher in participants allocated to colloids (OR 2.34, 95% CI 1.28 to 4.29, I² = 0%). Although the studies observed a higher risk of cerebral oedema (OR 0.20, 95% CI 0.02 to 1.74) and pneumonia (OR 0.58, 95% CI 0.17 to 2.01) with crystalloids, we could not exclude clinically important benefits or harms. </p> </section> <section id="CD011138-sec-0007"> <h3 class="title" id="CD011138-sec-0007">Authors' conclusions</h3> <p>We found no evidence that colloids were associated with lower odds of death or dependence in the medium term after stroke compared with crystalloids, though colloids were associated with greater odds of pulmonary oedema. We found no evidence to guide the best volume, duration, or mode of parenteral fluid delivery for people with acute stroke. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011138-abs-0004" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011138-abs-0004">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011138-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011138-abs-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011138-abs-0006">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD011138-abs-0005">Hrvatski</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011138-abs-0004" lang="en"> <h3>Fluids for people with stroke</h3> <p><b>Review question</b> </p> <p>What is the best fluid type, fluid volume, mode of fluid delivery, and duration of fluid treatment to reduce the risk of death or dependence in people with acute stroke? </p> <p><b>Background</b> </p> <p>Fluids given into a vein (intravenous, or iv) or under the skin (subcutaneous) are commonly used in people with stroke, but there are no clear guidelines on the best fluid management in such cases. There are a number of possible different types of fluid that can be used: isotonic fluids, or crystalloids are solutions that contain similar amounts of dissolved salts as in normal cells and blood, whilst hypertonic fluids, or colloids usually contain more (or larger) dissolved particles than in normal cells and blood. Fluid can also be given in different volumes, or for different durations. Hence, we searched the available literature to find answers to these questions. </p> <p><b>Study characteristics</b> </p> <p>The evidence is current to May 2015. We found 12 relevant studies (with 2351 participants) comparing colloids with crystalloids. Eleven of these studies included people with ischaemic stroke (stroke sustained due to a clot), whilst one study included people with haemorrhagic stroke (stroke due to a bleed). Five of these studies (1420 participants) also made a comparison between 0.9% saline, the most commonly prescribed iv fluid, and another fluid type. The largest study had 841 participants, whilst the smallest had 27 participants. The length of time that fluids were given varied between trials, from two hours to 10 days. </p> <p>Ten studies revealed a source of funding. Of these, two studies were funded by fluid manufacturers. </p> <p><b>Key results</b> </p> <p>We did not find any studies that examined the best fluid volume, mode of fluid delivery, or duration of fluid treatment. </p> <p>We found that people with acute stroke given crystalloids (including 0.9% saline) had about the same risk of death or dependence as people given other fluid types. People given crystalloids also had a lower risk of pulmonary oedema, a complication that can lead to breathlessness due to excess collection of watery fluid in the lungs. From the evidence we obtained, it was difficult to make any concrete conclusions about which fluids were better for reducing brain swelling (cerebral oedema) or a serious lung infection (pneumonia). </p> <p>We found no evidence to guide the best volume, duration, or mode of parenteral fluid delivery for people with acute stroke. </p> <p><b>Quality of the evidence</b> </p> <p>The majority of studies had a low to moderate risk of bias based on study limitations and inconsistency. Most studies reported the outcomes they stated they would. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011138-sec-0079" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011138-sec-0079"></div> <h3 class="title" id="CD011138-sec-0080">Implications for practice</h3> <section id="CD011138-sec-0080"> <p>Parenteral 0.9% saline and other crystalloids are widely used after acute stroke. We found no evidence that colloids were associated with lower odds of death or dependence in the medium term after stroke than saline or other crystalloids, but colloids were associated with greater odds of pulmonary oedema. There is therefore no evidence to support a change from using crystalloids in clinical practice. </p> </section> <h3 class="title" id="CD011138-sec-0081">Implications for research</h3> <section id="CD011138-sec-0081"> <p>Fluids are very commonly prescribed in acute stroke, although there is little evidence to support the type, volume, duration, or route of administration of this intervention. Further RCTs to address this uncertainty might lead to better fluid regimens in stroke, better advice for clinicians, and better outcomes for people with stroke. </p> <p>The review authors recommend collaborative trials in adults with acute stroke (ischaemic or haemorrhagic) in a hospital setting studying type, volume, varying administration routes, and frequency of fluid therapy over a fixed duration. Addressing all four questions might require more than one trial. Such trials should measure important clinical outcomes such as early and late death, dependence, and secondary complications of fluid therapy (for example pulmonary oedema, cerebral oedema, pneumonia). </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011138-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011138-sec-0022"></div> <div class="table" id="CD011138-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Colloids versus crystalloids for improving functional outcome in people with acute stroke</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Colloids versus crystalloids for improving functional outcome in people with acute stroke</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with acute ischaemic or haemorrhagic stroke<br/> <b>Settings:</b> all trials were undertaken in a hospital setting in various parts of the world including USA, UK, Europe, Israel, Australia, and Hong Kong<br/> <b>Intervention:</b> colloids versus crystalloids </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Colloids versus crystalloids</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Death or dependence</b> <br/> Follow‐up: 3‐12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.97</b> <br/> (0.79 to 1.21) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1420<br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>589 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>581 per 1000</b> <br/> (531 to 634) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>639 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>632 per 1000</b> <br/> (583 to 682) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Death</b> <br/> Follow‐up: 3‐12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 1.02</b> <br/> (0.82 to 1.27) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>2351<br/> (12 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>202 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>206 per 1000</b> <br/> (172 to 244) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>219 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>222 per 1000</b> <br/> (187 to 263) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Pneumonia</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.58</b> <br/> (0.17 to 2.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>416<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>33 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>20 per 1000</b> <br/> (6 to 65) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>33 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>19 per 1000</b> <br/> (6 to 64) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Cerebral oedema</b> <br/> Follow‐up: median 3 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.20</b> <br/> (0.02 to 1.74) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>200<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>49 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>10 per 1000</b> <br/> (1 to 82) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>49 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>10 per 1000</b> <br/> (1 to 82) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Pulmonary oedema</b> <br/> Follow‐up: median 90 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 2.34</b> <br/> (1.28 to 4.29) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>730<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>45 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>99 per 1000</b> <br/> (57 to 168) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>49 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>108 per 1000</b> <br/> (62 to 181) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in the footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <b>CI:</b> Confidence interval; <b>OR:</b> Odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded due to study limitations and inconsistency with substantial heterogeneity<br/> <sup>2</sup> Substantial heterogeneity<br/> <sup>3</sup> The confidence interval did not exclude important benefits or harms<br/> <sup>4</sup> Based on two studies, study limitations acknowledged<br/> <sup>5</sup> Data from one study only, no comparisons<br/> <sup>6</sup> Based on three studies, OR above 2.0 </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011138-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">0.9% saline versus other fluid for improving functional outcome in people with acute stroke</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>0.9% saline versus other fluid for improving functional outcome in people with acute stroke</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with acute ischaemic or haemorrhagic stroke<br/> <b>Settings: a</b> ll trials were undertaken in a hospital setting in various parts of the world including USA, UK, Europe, Israel, and Hong Kong<br/> <b>Intervention:</b> 0.9% saline versus other fluid </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> 0.9% saline versus other fluid</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Death or dependence</b> <br/> Follow‐up: 3‐12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 1.04</b> <br/> (0.82 to 1.32) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1120<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>553 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>563 per 1000</b> <br/> (503 to 620) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>540 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>550 per 1000</b> <br/> (490 to 608) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Death</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.87</b> <br/> (0.67 to 1.12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1760<br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>210 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>188 per 1000</b> <br/> (151 to 229) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>208 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>186 per 1000</b> <br/> (150 to 227) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Pneumonia</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 2.00</b> <br/> (0.36 to 11.16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>216<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>19 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>37 per 1000</b> <br/> (7 to 175) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>19 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>37 per 1000</b> <br/> (7 to 178) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Pulmonary oedema</b> <br/> Follow‐up: mean 48 hours </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.32</b> <br/> (0.14 to 0.69) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>424<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>121 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>41 per 1000</b> <br/> (19 to 87) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>121 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>41 per 1000</b> <br/> (19 to 87) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in the footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <b>CI:</b> Confidence interval; <b>OR:</b> Odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Study limitations acknowledged<br/> <sup>2</sup> Substantial heterogeneity<br/> <sup>3</sup> Unclear of blinding<br/> <sup>4</sup> Sample size lower than calculated<br/> <sup>5</sup> Incomplete reporting<br/> <sup>6</sup> Early termination of study </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011138-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD011138-sec-0023"></div> <p>In 2010, there were 16.9 million strokes globally, of which 5.9 million were fatal (<a href="./references#CD011138-bbs2-0063" title="FeiginVL , ForouzanfarMH , KrishnamurthiR , MensahGA , ConnorM , BennettDA , et al. Global and regional burden of stroke during 1990‐2010: findings from the Global Burden of Disease Study 2010. The Lancet2014;18(383):245‐54. ">Feigin 2014</a>). Stroke is the second‐leading cause of death and third‐leading cause of disability worldwide (<a href="./references#CD011138-bbs2-0062" title="FeiginVL . Stroke epidemiology in the developing world. The Lancet2005;365(9478):2160‐1. [PUBMED: 15978910] ">Feigin 2005</a>). Any small improvement in stroke management would therefore benefit many people. </p> <p>Parenteral fluids are a commonly used intervention in people with stroke who cannot swallow, and in whom dehydration is common (<a href="./references#CD011138-bbs2-0084" title="RowatA , GrahamC , DennisM . Dehydration in hospital‐admitted stroke patients. Stroke2012;43:857‐9. ">Rowat 2012</a>). Although swallow recovers in more than 80% of people within two to four weeks of stroke onset in the immediate poststroke period (<a href="./references#CD011138-bbs2-0065" title="GordonC , HewerRL , WadeDT . Dysphagia in acute stroke. British Medical Journal1987;295(6595):411‐4. [PUBMED: 3115478] ">Gordon 1987</a>), those with a poor swallow are at higher‐than‐average risk of dehydration. </p> <p>Parenteral fluids might be beneficial by reducing the ischaemic penumbra and improving cerebral perfusion (<a href="./references#CD011138-bbs2-0073" title="JauchEC , SaverJL , AdamsHPJr , BrunoA , ConnorsJJ , DemaerschalkBM , et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke2013;44(3):870‐947. [PUBMED: 23370205] ">Jauch 2013</a>), or influencing stroke progression (<a href="./references#CD011138-bbs2-0058" title="BrittonM , deFaireU , HelmersC . Hazards of therapy for excessive hypertension in acute stroke. Acta Medica Scandinavica1980;207(4):253‐7. [PUBMED: 7386220] ">Britton 1980</a>). They may reduce the risk of complications of dehydration such as infection, deep vein thrombosis, constipation, and the exacerbation of delirium (<a href="./references#CD011138-bbs2-0064" title="FinestoneHM , FoleyNC , WoodburyMG , Greene‐FinestoneL . Quantifying fluid intake in dysphagic stroke patients: a preliminary comparison of oral and nonoral strategies. Archives of Physical Medicine and Rehabilitation2001;82(12):1744‐6. [PUBMED: 11733894] ">Finestone 2001</a>; <a href="./references#CD011138-bbs2-0074" title="KellyJ , RuddA , LewisRR , CoshallC , ParmarK , MoodyA , et al. Screening for proximal deep vein thrombosis after acute ischemic stroke: a prospective study using clinical factors and plasma D‐dimers. Journal of Thrombosis and Haemostasis2004;2:1321‐6. ">Kelly 2004</a>; <a href="./references#CD011138-bbs2-0076" title="KositzkeJA . A question of balance—dehydration in the elderly. Journal of Gerontological Nursing1990;16(5):4‐11. [PUBMED: 2358648] ">Kositzke 1990</a>). Hence, parenteral fluids are widely used. </p> <p>However, parenteral fluids may also cause harm. Too much fluid can lead to cerebral or pulmonary oedema, cardiac failure, or hyponatraemia. Infection can develop around the sites of intravenous or subcutaneous cannulas that may lead to cellulitis or systemic infection. Indirect evidence that increased fluids might cause harm comes from the Glucose Insulin in Stroke Trial (GIST) trial, in which people who received the greatest volumes of infusion had the worst outcomes (although this may well be confounded by baseline glucose levels) (<a href="./references#CD011138-bbs2-0086" title="ScottJF , RobinsonGM , FrenchJM , O'ConnellJE , AlbertiKG , GrayCS . Glucose potassium insulin infusions in the treatment of acute stroke patients with mild to moderate hyperglycemia: the Glucose Insulin in Stroke Trial (GIST). Stroke1999;30(4):793‐9. [PUBMED: 10187881] ">Scott 1999</a>). Evidence from other conditions suggests that lower replacement volumes may be beneficial, for example in children with acute infection and in adults in intensive care (<a href="./references#CD011138-bbs2-0078" title="MaitlandK , KiguliS , OpokaRO , EngoruC , Olupot‐OlupotP , AkechSO , et al. Mortality after fluid bolus in African children with severe infection. The New England Journal of Medicine2011;364(26):2483‐95. ">Maitland 2011</a>; <a href="./references#CD011138-bbs2-0085" title="SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. The New England Journal of Medicine2004;350:2247‐56. ">SAFE 2004</a>). Furthermore, a sodium load with intravenous saline may lead to renal stress or hypertension (<a href="./references#CD011138-bbs2-0080" title="MyburghJA , MythenMG . Resuscitation fluids. The New England Journal of Medicine2013;369(13):1243‐51. [PUBMED: 24066745] ">Myburgh 2013</a>), and subcutaneous fluid regimens may not adequately replace potassium. </p> <p>There is little evidence to support different fluid regimens in people with acute stroke. Haemodilution regimens (which aim to reduce blood viscosity) have been studied in many trials, though they are not widely used in clinical practice. A Cochrane review concluded that there was "no clear evidence of benefit of haemodilution therapy for acute ischaemic stroke" (<a href="./references#CD011138-bbs2-0059" title="ChangTS , JensenMB . Haemodilution for acute ischaemic stroke. Cochrane Database of Systematic Reviews2014, Issue 8. [DOI: 10.1002/14651858.CD000103.pub2] ">Chang 2014</a>). </p> <p>A systematic review that provided clear information on evidence related to the effects of different fluid regimens on important clinical outcomes in people with acute stroke would therefore be very useful for clinicians and researchers. Strong evidence would assist healthcare professionals in better managing parenteral fluid prescription in people with acute stroke. </p> <section id="CD011138-sec-0024"> <h3 class="title" id="CD011138-sec-0024">Description of the condition</h3> <p>In 1978, the World Health Organization defined stroke as a "neurological deficit of cerebrovascular cause that persists beyond 24 hours or is interrupted by death within 24 hours." (<a href="./references#CD011138-bbs2-0090" title="World Health Organization. Cerebrovascular Disorders. Geneva: World Health Organization, 1978. ">WHO 1978</a>). About 80% of strokes are ischaemic (caused by interruption of the blood supply to an area of the brain), and the remaining 20% are haemorrhagic (mainly due to an abnormal vascular structure or to rupture of a vessel) (<a href="./references#CD011138-bbs2-0087" title="SimsNR , MuydermanH . Mitochondria, oxidative metabolism and cell death in stroke. Biochimica et Biophysica Acta2010;1802(1):80‐91. [PUBMED: 19751827] ">Sims 2010</a>). We will not consider subarachnoid haemorrhage, which has a different cause and prognosis from ischaemic and haemorrhagic strokes, in this review. A significant proportion of stroke survivors are left with an impairment of physical, psychological, and social domains (<a href="./references#CD011138-bbs2-0077" title="Lopez‐EspuelaF , ZamoranoJD , Ramírez‐MorenoJM , Jiménez‐CaballeroPE , Portilla‐CuencaJC , Lavado‐GarcíaJM , et al. Determinants of quality of life in stroke survivors after 6 months, from a comprehensive stroke unit: a longitudinal study. Biological Research for Nursing2014;epub ahead of print:pii: 1099800414553658. ">Lopez‐Espuela 2014</a>; <a href="./references#CD011138-bbs2-0082" title="ReithJ , JorgensenHS , NakayamaH , RaaschouHO , OlsenTS . Seizures in acute stroke: predictors and prognostic significance. The Copenhagen Stroke Study. Stroke1997;28(8):1585‐9. [PUBMED: 9259753] ">Reith 1997</a>). Between 20% and 50% die within the first month, depending on the type and severity of the stroke, the age of the person, comorbidities, and effectiveness of treatment for complications (<a href="./references#CD011138-bbs2-0089" title="TruelsenT , BeggS , MathersC . The global burden of cerebrovascular disease. World Health Organization. http://www.who.int/healthinfo/statistics/bod_cerebrovasculardiseasestroke.pdf2000. ">Truelsen 2000</a>). </p> </section> <section id="CD011138-sec-0025"> <h3 class="title" id="CD011138-sec-0025">Description of the intervention</h3> <p>Parenteral intravenous or subcutaneous fluids replace or supplement oral fluid intake. The UK National Institute for Health and Care Excellence (NICE) guidance on fluid prescription in all medical inpatients suggests that the volume and type of fluid therapy should be modified depending on patient weight, acid base and electrolyte disturbances and insensible losses (<a href="./references#CD011138-bbs2-0081" title="NICE: National Institute for Health and Care Excellence. Intravenous fluid therapy in adults in hospital. http://www.nice.org.uk/guidance/index.jsp?action=byID&amp;o=143302013. ">NICE 2013</a>). However, there is little randomised evidence to support this strategy in people with stroke. </p> <p>We aimed to explore the effects of the following aspects of parenteral fluid delivery.</p> <p> <ol id="CD011138-list-0001"> <li> <p>Type of fluid.</p> </li> <li> <p>Volume of fluid.</p> </li> <li> <p>Duration of fluid administration.</p> </li> <li> <p>Mode of delivery.</p> </li> </ol> </p> </section> <section id="CD011138-sec-0026"> <h3 class="title" id="CD011138-sec-0026">How the intervention might work</h3> <p>Parenteral fluids in people with acute stroke may lead to different outcomes, depending on fluid type, volume, duration, and mode of delivery. Possible effects of each of these are as follows. </p> <section id="CD011138-sec-0027"> <h4 class="title">Type of fluid</h4> <p> <ol id="CD011138-list-0002"> <li> <p>Isotonic (or crystalloids)</p> <ol id="CD011138-list-0003"> <li> <p>Isotonic saline: a solution of 0.9% sodium chloride weight by volume ('normal saline'). When given parenterally, it distributes throughout the extracellular fluid compartment, with only 25% remaining in the intravascular compartment. Because it has a high sodium content, large volumes can lead to water and salt retention (<a href="./references#CD011138-bbs2-0081" title="NICE: National Institute for Health and Care Excellence. Intravenous fluid therapy in adults in hospital. http://www.nice.org.uk/guidance/index.jsp?action=byID&amp;o=143302013. ">NICE 2013</a>). </p> </li> <li> <p>Glucose (dextrose) 5%: this fluid is usually used to replace losses of free water; such losses may lead to worsening of cerebral oedema. However, it can increase the risk of hyponatraemia and lead to hyperglycaemia in people with diabetes. </p> </li> <li> <p>Intravenous 0.18% saline/4% glucose solution: there is a risk of hyponatraemia if given rapidly or in excess. </p> </li> <li> <p>Balanced crystalloid solutions (e.g. Ringer's lactate, Hartmann's, Plasma‐Lyte, Sterofundin): these fluids have similar properties to 0.9% saline in terms of volume of distribution. However, because of the lower concentration of sodium, they may be associated with less sodium retention. These might be useful in maintenance regimens, and are frequently used after surgery. </p> </li> </ol> </li> <li> <p>Hypertonic (largely colloids)</p> <ol id="CD011138-list-0004"> <li> <p>Colloid solutions: colloid solutions contain macromolecules such as albumin, dextran, mannitol, or hydroxyethyl starch. They may expand intravascular volume more rapidly than crystalloids; however, their cost, risk of anaphylactic reactions, and association with worsening renal function may outweigh any putative physiological advantages. </p> </li> </ol> </li> </ol> </p> </section> <section id="CD011138-sec-0028"> <h4 class="title">Volume of fluid</h4> <p>Fluid therapy can be targeted based on a person's renal function or hydration state. However, fluid targets may be too generous, or not give sufficient replacement, leading to problems with: </p> <p> <ol id="CD011138-list-0005"> <li> <p>greater volumes of fluid: cerebral oedema, respiratory distress, cardiac failure, and hyponatraemia; </p> </li> <li> <p>lesser volumes of fluid: acute kidney injury, deep vein thrombosis, delirium, and infection. </p> </li> </ol> </p> </section> <section id="CD011138-sec-0029"> <h4 class="title">Duration of fluid administration</h4> <p> <ol id="CD011138-list-0006"> <li> <p>A longer period of fluid administration could lead to complications associated with overhydration and intravenous or subcutaneous cannulation. </p> </li> <li> <p>A shorter period of fluid administration could lead to complications associated with dehydration. </p> </li> </ol> </p> </section> <section id="CD011138-sec-0030"> <h4 class="title">Mode of delivery</h4> <p> <ol id="CD011138-list-0007"> <li> <p>Intravenous fluids might lead to more rapid fluid resuscitation than subcutaneous fluids, though their use may increase the risk of cannula‐associated infection. </p> </li> <li> <p>Use of subcutaneous fluids might be easier and carries a lower infection risk (<a href="./references#CD011138-bbs2-0015" title="ChallinerYC , JarrettD , HaywardMJ , al‐JubouriMA , JuliousSA . A comparison of intravenous and subcutaneous hydration in elderly acute stroke patients. Postgraduate Medical Journal1994;70(821):196‐7. ">Challiner 1994</a>). However, this practice limits the rate of fluid administration, can cause unsightly skin blebs, and may lead to hypokalaemia, as potassium replacement is not possible through the subcutaneous route. </p> </li> </ol> </p> </section> </section> <section id="CD011138-sec-0031"> <h3 class="title" id="CD011138-sec-0031">Why it is important to do this review</h3> <p>The current NICE guideline for the use of intravenous fluids in medical patients highlights the lack of systematic reviews and clinical trials to guide fluid treatment of inpatients, including people with stroke (<a href="./references#CD011138-bbs2-0081" title="NICE: National Institute for Health and Care Excellence. Intravenous fluid therapy in adults in hospital. http://www.nice.org.uk/guidance/index.jsp?action=byID&amp;o=143302013. ">NICE 2013</a>). The guideline found no trial evidence to support different types of maintenance fluid, different durations of fluid replacement, or optimal volume of fluid. We sought to determine whether there was evidence to support parenteral fluid prescription in people with stroke. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011138-sec-0032" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011138-sec-0032"></div> <p>To assess whether different parenteral fluid regimens lead to differences in death, or death or dependence, after stroke based on fluid type, fluid volume, duration of fluid administration, and mode of delivery. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011138-sec-0033" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011138-sec-0033"></div> <section id="CD011138-sec-0034"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011138-sec-0035"> <h4 class="title">Types of studies</h4> <p>We considered all published and unpublished randomised controlled trials (RCTs) in which parenteral fluids had been used as an intervention to improve outcome after stroke. We also considered cluster‐randomised trials. We included trials with or without blinding of assessors or participants. We excluded quasi‐randomised, non‐randomised, and cross‐over trials. </p> </section> <section id="CD011138-sec-0036"> <h4 class="title">Types of participants</h4> <p>We included trials of parenteral fluid replacement therapy within seven days of stroke onset in adults (aged 18 years or older) of any gender or ethnicity. We planned to examine subgroups of participants by their ability to swallow, if these data were available. </p> <p>We included trials of participants with ischaemic or haemorrhagic stroke (but not subarachnoid haemorrhage). We included all types, severities, and stages of stroke, and confirmation of the diagnosis using imaging was not compulsory. The diagnosis should be made by a doctor on either clinical or radiological grounds. </p> <p>This review focused on the immediate period (within one week) poststroke; therefore, trials in all settings (for example rehabilitation ward, community, nursing home) in that period were eligible. </p> <p>We considered the inclusion of studies in which only a subset of participants had suffered a stroke if a relevant outcome measure was reported for these participants. </p> </section> <section id="CD011138-sec-0037"> <h4 class="title">Types of interventions</h4> <p>We sought studies that compared:</p> <p> <ol id="CD011138-list-0008"> <li> <p>types of fluid:</p> <ol id="CD011138-list-0009"> <li> <p>use of colloids versus crystalloids;</p> </li> <li> <p>use of 0.9% saline versus other fluid types (e.g. colloids, other crystalloids);</p> </li> </ol> </li> <li> <p>volumes of fluids:</p> <ol id="CD011138-list-0010"> <li> <p>greater versus lesser fluid volumes or no fluid;</p> </li> <li> <p>administration of a fixed volume versus a targeted volume;</p> </li> </ol> </li> <li> <p>durations of fluid administration:</p> <ol id="CD011138-list-0011"> <li> <p>continuously versus intermittently;</p> </li> <li> <p>longer duration versus shorter duration;</p> </li> </ol> </li> <li> <p>mode of delivery:</p> <ol id="CD011138-list-0012"> <li> <p>intravenous versus subcutaneous.</p> </li> </ol> </li> </ol> </p> <p>We anticipated that studies of these comparisons would report variations in dosage or intensity, mode of delivery (intravenous versus subcutaneous), personnel delivering the intervention, frequency of delivery, and duration and timing of delivery. If data were available on these factors, we aimed to collect them. We were unable to define thresholds for the comparison of more versus less or no fluid, or the duration of treatment, as the standard volume or duration of treatment is not defined in guidelines. We had planned to dichotomise our analysis at median term duration or fluid volume delivered. However, we found no completed studies that addressed these questions. We documented the regimen and delivery of the intervention and attempted to contact study authors when this information was unavailable or unclear. </p> </section> <section id="CD011138-sec-0038"> <h4 class="title">Types of outcome measures</h4> <p>Our primary outcome was death or dependence less than six months after stroke. Our secondary outcomes were short‐term complications of fluid therapies. </p> <p>A number of scales have been used in stroke research to assess functional outcome poststroke (<a href="./references#CD011138-bbs2-0060" title="DeHaanR , HornJ , LimburgM , Van DerMeulenJ , BossuytP . A comparison of five stroke scales with measures of disability, handicap, and quality of life. Stroke1993;24(8):1178‐81. [PUBMED: 8342193] ">De Haan 1993</a>); the most common is the modified Rankin Scale (mRS) (<a href="./references#CD011138-bbs2-0056" title="BanksJL , MarottaCA . Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke2007;38(3):1091‐6. [PUBMED: 17272767] ">Banks 2007</a>), which measures activity limitation and participation restriction. The mRS dichotomises people who are dependent or dead (mRS 3 to 6), and people who are independent, and also people who are dead versus those who are alive. </p> <p>The mRS measures functional outcome poststroke as:</p> <p> <ul id="CD011138-list-0013"> <li> <p>0: no symptoms at all;</p> </li> <li> <p>1: no significant disability despite symptoms; ability to carry out all usual duties and activities; </p> </li> <li> <p>2: slight disability; inability to carry out all previous activities with ability to look after own affairs without assistance; </p> </li> <li> <p>3: moderate disability requiring some help but with ability to walk without assistance;</p> </li> <li> <p>4: moderately severe disability; inability to walk without assistance and inability to attend to own bodily needs; </p> </li> <li> <p>5: severe disability; state of being bedridden and incontinent and requiring constant nursing care and attention; </p> </li> <li> <p>6: death.</p> </li> </ul> </p> <p>We anticipated that most studies would use the mRS to assess outcome poststroke. We considered sensible dichotomies of other outcome scales such as the Oxford Handicap Scale and the Barthel Index to define dependence (<a href="./references#CD011138-bbs2-0055" title="BamfordJM , SandercockPA , WarlowCP , SlatteryJ . Interobserver agreement for the assessment of handicap in stroke patients. Stroke1989; Vol. 20, issue 6:828. [PUBMED: 2728057] ">Bamford 1989</a>; <a href="./references#CD011138-bbs2-0067" title="GrangerCV , DewisLS , PetersNC , SherwoodCC , BarrettJE . Stroke rehabilitation: analysis of repeated Barthel Index measures. Archives of Physical Medicine and Rehabilitation1979;60(1):14‐7. [PUBMED: 420565] ">Granger 1979</a>). </p> <section id="CD011138-sec-0039"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD011138-list-0014"> <li> <p>Death or dependence less than six months poststroke (measured as mRS grade 2 or more, or measured with other outcome scales). </p> </li> </ol> </p> </section> <section id="CD011138-sec-0040"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD011138-list-0015"> <li> <p>Death at 12 months or sooner after stroke</p> </li> <li> <p>Complications potentially attributable to fluid therapy: pneumonia, pulmonary oedema, cerebral oedema, and renal failure. </p> </li> </ol> </p> <p>If we had gathered sufficient data, we aimed to examine the following subgroups.</p> <p> <ol id="CD011138-list-0016"> <li> <p>Stroke type (i.e. ischaemic versus haemorrhagic).</p> </li> <li> <p>Ability to swallow.</p> </li> </ol> </p> </section> </section> </section> <section id="CD011138-sec-0041"> <h3 class="title">Search methods for identification of studies</h3> <p>See the 'Specialized register' section in the <a href="http://onlinelibrary.wiley.com/o/cochrane/clabout/articles/STROKE/frame.html" target="_blank">Cochrane Stroke Group</a> module. We searched for trials in all languages and formats and arranged for translation of relevant papers published in languages other than English. We adhered to copyright legislation and the terms of database licensing agreements. </p> <section id="CD011138-sec-0042"> <h4 class="title">Electronic searches</h4> <p>We searched the Cochrane Stroke Group Trials Register (May 2015) and the following electronic databases and trials registers. </p> <p> <ol id="CD011138-list-0017"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) (Cochrane Library 2015, Issue 5) (<a href="./appendices#CD011138-sec-0085">Appendix 1</a>). </p> </li> <li> <p>Cochrane Database of Systematic Reviews (CDSR) (Cochrane Library 2015, Issue 5) (<a href="./appendices#CD011138-sec-0085">Appendix 1</a>). </p> </li> <li> <p>Database of Abstracts of Reviews of Effects (DARE) (Cochrane Library 2015, Issue 5) (<a href="./appendices#CD011138-sec-0085">Appendix 1</a>). </p> </li> <li> <p>MEDLINE (Ovid) (January 2008 to May 2015) (<a href="./appendices#CD011138-sec-0086">Appendix 2</a>). </p> </li> <li> <p>EMBASE (Ovid) (January 2008 to May 2015) (<a href="./appendices#CD011138-sec-0087">Appendix 3</a>). </p> </li> <li> <p>CINAHL (EBSCO) (1982 to May 2015) (<a href="./appendices#CD011138-sec-0088">Appendix 4</a>). </p> </li> <li> <p>Stroke Trials Registry (www.strokecenter.org/trials/) (May 2015) (<a href="./appendices#CD011138-sec-0089">Appendix 5</a>). </p> </li> <li> <p>National Research Register Archive (https://portal.nihr.ac.uk/Pages/NRRArchiveSearch.aspx) (May 2015) (<a href="./appendices#CD011138-sec-0089">Appendix 5</a>). </p> </li> <li> <p>ClinicalTrials.gov (http://clinicaltrials.gov/) (May 2015) (<a href="./appendices#CD011138-sec-0089">Appendix 5</a>). </p> </li> <li> <p>ISRCTN Registry (http://www.isrctn.com/) (May 2015) (<a href="./appendices#CD011138-sec-0089">Appendix 5</a>). </p> </li> </ol> </p> <p>We developed the search strategies in collaboration with the Cochrane Stroke Group Trials Search Co‐ordinator. Using a comprehensive search strategy, the Cochrane Stroke Group Trials Search Co‐ordinator had already completed a retrospective search of MEDLINE and EMBASE for all stroke trials to January 2008 and added all relevant trials to the Stroke Group Trials Register. To avoid duplication of effort we have limited the search of MEDLINE and EMBASE from January 2008 onwards. </p> </section> <section id="CD011138-sec-0043"> <h4 class="title">Searching other resources</h4> <p>We attempted to identify further published, unpublished, and ongoing trials by:</p> <p> <ol id="CD011138-list-0018"> <li> <p>searching reference lists from included studies, published reviews, and relevant papers;</p> </li> <li> <p>using Science Citation Index Cited Reference Search for forward tracking of relevant papers; </p> </li> <li> <p>contacting study authors and researchers active in the field.</p> </li> </ol> </p> </section> </section> <section id="CD011138-sec-0044"> <h3 class="title" id="CD011138-sec-0044">Data collection and analysis</h3> <section id="CD011138-sec-0045"> <h4 class="title">Selection of studies</h4> <p>We managed all records identified from the electronic searches with reference management software and removed duplicate records. One review author (AV) screened titles and abstracts of references obtained as a result of our search and excluded irrelevant papers. Two review authors (WW and AV) retrieved full‐text articles of the remaining references and independently assessed each study for inclusion in the review on the basis of eligibility criteria. We identified and recorded the reasons for exclusion of ineligible studies. To avoid double counting the same participants, if a study published data more than once, we used the publication with the largest number of participants. </p> <p>Both WW and AV independently collected data, including names of study authors, specific details of interventions (for example dose, frequency), numbers of participants, date and duration of the study, and results and then applied the eligibility criteria to all of the screened studies. </p> <p>Together, the same two review authors (WW and AV) ran a pilot test on a sample of reports (approximately 10 to 12 papers) to ensure consistency between review authors. One review author (MD) was available to resolve disagreements. </p> <p>We recorded the selection process and completed a PRISMA flow diagram (<a href="#CD011138-fig-0001">Figure 1</a>). </p> <div class="figure" id="CD011138-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD011138-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_n/nCD011138-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD011138-sec-0046"> <h4 class="title">Data extraction and management</h4> <p>We used a predesigned data extraction form to extract data from studies that met the inclusion criteria. Two review authors (WW and AV) independently documented the following information. </p> <p> <ol id="CD011138-list-0019"> <li> <p>Source of data, including study ID, report ID, review author ID, and citation and contact details. </p> </li> <li> <p>Methods: study design, total study duration, method of randomisation, allocation concealment, risk of bias, blinding, and follow‐up. </p> </li> <li> <p>Participants: total number, setting, age, sex, type of stroke, method of stroke diagnosis, severity of disability recorded, and assessment of swallow. </p> </li> <li> <p>Interventions: type of intervention poststroke, more versus less fluid, type of fluid given, and duration and timing of fluids. </p> </li> <li> <p>Outcomes: primary and secondary outcomes and time to outcome measure.</p> </li> <li> <p>Miscellaneous: any funding source, references to other relevant studies, and comments by review authors. </p> </li> </ol> </p> <p>The review authors resolved data extraction discrepancies through discussion. We consulted the third review author (MD) to resolve uncertainty or continued disagreement. We managed extracted data by entering them directly into RevMan 5.3 (<a href="./references#CD011138-bbs2-0083" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). </p> </section> <section id="CD011138-sec-0047"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (AV and WW) independently assessed each included study using Cochrane's tool for assessing risk of bias, as outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i>(<a href="./references#CD011138-bbs2-0070" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane‐handbook.org. ">Higgins 2011</a>). We extracted data into 'Risk of bias' tables, where each entry was graded as 'low risk', 'high risk', or 'unclear risk'. We created plots of 'Risk of bias' assessments using RevMan 5.3. As per the 'Risk of bias' tool, we considered the following domains. </p> <p> <ol id="CD011138-list-0020"> <li> <p>Sequence generation (selection bias)</p> </li> <li> <p>Allocation sequence concealment (selection bias)</p> </li> <li> <p>Blinding of participants and personnel (performance bias)</p> </li> <li> <p>Blinding of outcome assessment (detection bias)</p> </li> <li> <p>Incomplete outcome data (attrition bias)</p> </li> <li> <p>Selective outcome reporting (reporting bias)</p> </li> <li> <p>Other potential sources of bias</p> </li> </ol> </p> <p>We tested assessments of the risk of bias within our review team on a pilot sample with varying range of bias to ensure that we applied the criteria consistently and that we could reach consensus. We discussed disagreements and when necessary consulted a third review author (MD) to achieve a consensus. </p> </section> <section id="CD011138-sec-0048"> <h4 class="title">Measures of treatment effect</h4> <p>We used RevMan 5.3 to meta‐analyse study level measures of effect (<a href="./references#CD011138-bbs2-0083" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We used odds ratios (ORs) with 95% confidence intervals (CIs) to report results for dichotomous (binary) data. We calculated the absolute differences in event rates using the GRADEpro software (<a href="./references#CD011138-bbs2-0066" title="GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. McMaster University, 2015 (developed by Evidence Prime, Inc.). Available from www.gradepro.org. ">GRADEpro GDT 2015</a>) and used total event rate in the control arm of the pooled results (<a href="./full#CD011138-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD011138-tbl-0002">summary of findings Table 2</a>). We used fixed‐effect meta‐analyses to summarise the effect of fluids on outcome after stroke and random‐effects models for sensitivity analyses. </p> </section> <section id="CD011138-sec-0049"> <h4 class="title">Unit of analysis issues</h4> <p>We took into account the level at which randomisation occurred in each study. We obtained only study level data. We examined outcomes at three to six months poststroke. We analysed the outcomes of dependence and death as dichotomous data. We used 2 × 2 tables, with effects of the intervention expressed as ORs. </p> </section> <section id="CD011138-sec-0050"> <h4 class="title">Dealing with missing data</h4> <p>When necessary, we attempted to contact the original investigators to request missing data. We did not use replacement values in place of missing data. </p> </section> <section id="CD011138-sec-0051"> <h4 class="title">Assessment of heterogeneity</h4> <p>We used the I² statistic to measure heterogeneity among the trials in each analysis (<a href="./references#CD011138-bbs2-0069" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. [PUBMED: 12958120] ">Higgins 2003</a>). We considered values of 50% and above as representing significant heterogeneity. </p> </section> <section id="CD011138-sec-0052"> <h4 class="title">Assessment of reporting biases</h4> <p>We carefully assessed each included study for risk of bias as outlined above. We used a comprehensive search strategy to minimise reporting bias by searching relevant electronic sources and other trials registers. We tried to identify unpublished studies and considered their inclusion. We considered the use of funnel plots to investigate publication bias (<a href="./references#CD011138-bbs2-0061" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ1997;315(7109):629‐34. ">Egger 1997</a>), but there were too few trials. </p> </section> <section id="CD011138-sec-0053"> <h4 class="title">Data synthesis</h4> <p>We constructed forest plots to compare four intervention groups: type of fluid (0.9% saline versus others, colloids versus crystalloids), volume of fluid (more versus less (or none), fixed versus targeted), duration of fluid administration (intermittent versus continuous, longer versus shorter), and mode of delivery (intravenous versus subcutaneous), where data, if any, were available. We analysed dichotomous outcome data as dependence or death versus independence. </p> <p>We calculated the effects of the intervention with a fixed‐effect model in RevMan 5.3 and reported them as ORs with 95% CIs (<a href="./references#CD011138-bbs2-0083" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). </p> </section> <section id="CD011138-sec-0054"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We had planned to carry out the following analyses (if sufficient data were available):</p> <p> <ol id="CD011138-list-0021"> <li> <p>different stroke type: ischaemic versus haemorrhagic;</p> </li> <li> <p>ability to swallow.</p> </li> </ol> </p> <p>However, during our review process, we did not find data to perform these analyses.</p> </section> <section id="CD011138-sec-0055"> <h4 class="title">Sensitivity analysis</h4> <p>We considered performing sensitivity analysis if results were reported by stroke subtype or the ability to swallow. However, none of our studies reported the latter. For the former, only one included study studied people with haemorrhagic stroke, hence this analysis was not possible. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011138-sec-0056" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011138-sec-0056"></div> <section id="CD011138-sec-0057"> <h3 class="title">Description of studies</h3> <p>See: <a href="./references#CD011138-sec-0098" title="">Characteristics of included studies</a>; <a href="./references#CD011138-sec-0099" title="">Characteristics of excluded studies</a>. </p> <p>Two trials had completed recruitment but not published results at the time of the review (<a href="./references#CD011138-bbs2-0037" title="OghbaeiM . The effect of intravenous albumin in mortality and morbidity of intracranial hemorrhage; a randomized clinical trial. Iranian Registry of Clinical Trials http://irct.ir/searchresult.php?keyword=fibrinogen&amp;id=8240&amp;field=&amp;number=1&amp;prt=31&amp;total=5&amp;m=12012. ">Oghbaei 2012</a>; <a href="./references#CD011138-bbs2-0041" title="ShalilahmadiD . Assessment of the effect of albumin compared with placebo on the reduction of the hematoma volume in patients with hemorrhagic stroke referred to Ahvaz Golestan Hospital. Iranian Registry of Clinical Trials http://irct.ir/searchresult.php?keyword=fibrinogen&amp;id=8574&amp;field=&amp;number=1&amp;prt=73&amp;total=5&amp;m=12013. ">Shalilahmadi 2013</a>). We were unable to contact the authors to determine a publication date. We were also unable to extract enough data from one conference proceeding (<a href="./references#CD011138-bbs2-0022" title="GreenhallRCD . Clinical and neuropathological observations in a controlled trial of low molecular weight dextran (LMD) in acute cerebral infarction. Neuropathology and Applied Neurobiology1974;1(1):108. ">Greenhall 1974</a>). </p> <p>From our initial protocol, we had planned four comparisons:</p> <p> <ol id="CD011138-list-0022"> <li> <p>type of fluids (colloids versus crystalloids, 0.9% saline versus others);</p> </li> <li> <p>volume of fluids (greater versus less (or none), fixed versus targeted);</p> </li> <li> <p>duration of fluid delivery (continuous versus intermittent, longer versus shorter duration); and </p> </li> <li> <p>mode of delivery (intravenous versus subcutaneous).</p> </li> </ol> </p> <p>Data were only available for a comparison between fluid types (colloids versus crystalloids and 0.9% saline versus others). </p> <section id="CD011138-sec-0058"> <h4 class="title">Results of the search</h4> <p>We identified 14,199 publications from our database searches and searches from other sources. After the removal of 670 duplicates, 13,529 publications remained for screening. After initial screening of titles and abstracts, 183 publications remained for further evaluation. We obtained the full‐text articles for these records, and two review authors (AV and WW) independently screened them. After discussion, we excluded a further 130 records, leaving 53 records for further evaluation. Eight required translation (two German, one Dutch, one Italian, one Hebrew, and three Chinese) (see PRISMA flow diagram <a href="#CD011138-fig-0001">Figure 1</a>). </p> <p>After we screened the full texts and extracted data, 12 studies met our inclusion criteria, and we excluded 41 studies (see <a href="./references#CD011138-sec-0098" title="">Characteristics of included studies</a>; <a href="./references#CD011138-sec-0099" title="">Characteristics of excluded studies</a>). One study is still recruiting participants (due completion 2016) (<a href="./references#CD011138-bbs2-0054" title="SuwanwelaNC . Randomised controlled study of the effectiveness of iv fluid infusion in patients with acute ischemic stroke (IVIS). clinicaltrials.gov/ct2/show/NCT02003794(accessed May 2015). ">NCT02003794</a>; see <a href="./references#CD011138-sec-0100" title="">Characteristics of ongoing studies</a>). </p> </section> <section id="CD011138-sec-0059"> <h4 class="title">Included studies</h4> <p>Of the 12 relevant studies, 11 studies recruited only people with ischaemic stroke, and one study, <a href="./references#CD011138-bbs2-0012" title="YuY , KumanaCR , LauderIJ , CheungYK , ChanFL , KouM , et al. Treatment of acute cerebral hemorrhage with intravenous glycerol. A double‐blind, placebo‐controlled, randomized trial. Stroke1992;23(7):967‐71. ">Yu 1992</a>, recruited people with haemorrhagic stroke. The largest trial, ALIAS 2, randomised 841 participants to 25% albumin versus 0.9% sodium chloride (<a href="./references#CD011138-bbs2-0008" title="GinsbergMD , PaleschYY , HillMD , MartinRH , MoyCS , BarsanWG , et al. High‐dose albumin treatment for acute ischaemic stroke (ALIAS) part 2: a randomised, double‐blind, phase 3, placebo‐controlled trial. The Lancet Neurology2013;12:1049‐58. ">Ginsberg 2013</a>). This trial was stopped early due to futility. The smallest trial recruited and randomised 27 participants into two arms: dextran 40 versus 5% dextrose (<a href="./references#CD011138-bbs2-0009" title="LarssonO , MarinovichN , BarberK . Double‐blind trial of glycerol therapy in early stroke. The Lancet1976;1:832‐4. ">Larsson 1976</a>). </p> <p>The 12 included studies recruited a total of 2351 participants: 1185 allocated to colloids and 1166 allocated to crystalloids. All participants were in a hospital setting. Timing between the stroke to recruitment varied between trials: seven trials recruited participants within 24 hours of a stroke (<a href="./references#CD011138-bbs2-0001" title="AichnerFT , FazekasF , BraininM , PolzW , MamoliB , ZeilerK . Hypervolemic hemodilution in acute ischemic stroke. The Multicenter Austrian Hemodilution Stroke Trial (MAHST). Stroke1998;29:743‐9. ">Aichner 1998</a>; <a href="./references#CD011138-bbs2-0003" title="BorensteinN , RegevI , FlechaterS , StreiflerM , VardiJ . Dextran‐40 in nonhemorrhagic cerebrovascular accidents. Harefuah1981;100(10):455. ">Borenstein 1981</a>; <a href="./references#CD011138-bbs2-0007" title="GinsbergMD , PaleschYY , MartinRH , HillMD , MoyCS , WaldmanBD , et al. The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. Stroke2011;42:119‐27. ">Ginsberg 2011</a>; <a href="./references#CD011138-bbs2-0008" title="GinsbergMD , PaleschYY , HillMD , MartinRH , MoyCS , BarsanWG , et al. High‐dose albumin treatment for acute ischaemic stroke (ALIAS) part 2: a randomised, double‐blind, phase 3, placebo‐controlled trial. The Lancet Neurology2013;12:1049‐58. ">Ginsberg 2013</a>; <a href="./references#CD011138-bbs2-0009" title="LarssonO , MarinovichN , BarberK . Double‐blind trial of glycerol therapy in early stroke. The Lancet1976;1:832‐4. ">Larsson 1976</a>; <a href="./references#CD011138-bbs2-0011" title="RudolfJ . Hydroxyethyl starch for hypervolemic hemodilution in patients with acute ischemic stroke: a randomized, placebo‐controlled phase II safety study. Cerebrovascular Diseases2002;14(1):33‐41. ">Rudolf 2002</a>; <a href="./references#CD011138-bbs2-0012" title="YuY , KumanaCR , LauderIJ , CheungYK , ChanFL , KouM , et al. Treatment of acute cerebral hemorrhage with intravenous glycerol. A double‐blind, placebo‐controlled, randomized trial. Stroke1992;23(7):967‐71. ">Yu 1992</a>), three trials recruited participants within 48 hours (<a href="./references#CD011138-bbs2-0002" title="BayerAJ , PathyMSJ , NewcombeR . Double‐blind randomised trial of intravenous glycerol in acute stroke. The Lancet1987;1:405‐8. ">Bayer 1987</a>; <a href="./references#CD011138-bbs2-0004" title="FawerR , JustafreJC , BergerJP , SchellingJL . Intravenous glycerol in cerebral infarction: a controlled 4 month trial. Stroke1978;9:484‐6. ">Fawer 1978</a>; <a href="./references#CD011138-bbs2-0010" title="MatthewsWB , OxburyJM , GraingerKM , GreenhallRC . A blind controlled trial of dextran 40 in the treatment of ischaemic stroke. Brain1976;99:193‐206. ">Matthews 1976</a>), and one trial within 72 hours (<a href="./references#CD011138-bbs2-0006" title="GilroyJ , BarnhartM , MeyerJS . Treatment of acute stroke with Dextran 40. JAMA1969;210(2):293‐8. ">Gilroy 1969</a>). In one study the timing after stroke for recruitment was unclear (<a href="./references#CD011138-bbs2-0005" title="FriedliW , ImbachP , Ghisleni‐SteineggerS , SchwarzC , MaireP . Treatment with 10% glycerin in acute ischaemic cerebral infarct. Double blind study. Schweizerische Medizinische Wochenschrift1979;109(20):737‐42. ">Friedli 1975</a>). </p> <p>The trials studied fluids that were hypertonic (colloids): hydroethyl starch (<a href="./references#CD011138-bbs2-0001" title="AichnerFT , FazekasF , BraininM , PolzW , MamoliB , ZeilerK . Hypervolemic hemodilution in acute ischemic stroke. The Multicenter Austrian Hemodilution Stroke Trial (MAHST). Stroke1998;29:743‐9. ">Aichner 1998</a>; <a href="./references#CD011138-bbs2-0011" title="RudolfJ . Hydroxyethyl starch for hypervolemic hemodilution in patients with acute ischemic stroke: a randomized, placebo‐controlled phase II safety study. Cerebrovascular Diseases2002;14(1):33‐41. ">Rudolf 2002</a>), 10% glycerol (<a href="./references#CD011138-bbs2-0002" title="BayerAJ , PathyMSJ , NewcombeR . Double‐blind randomised trial of intravenous glycerol in acute stroke. The Lancet1987;1:405‐8. ">Bayer 1987</a>; <a href="./references#CD011138-bbs2-0004" title="FawerR , JustafreJC , BergerJP , SchellingJL . Intravenous glycerol in cerebral infarction: a controlled 4 month trial. Stroke1978;9:484‐6. ">Fawer 1978</a>; <a href="./references#CD011138-bbs2-0005" title="FriedliW , ImbachP , Ghisleni‐SteineggerS , SchwarzC , MaireP . Treatment with 10% glycerin in acute ischaemic cerebral infarct. Double blind study. Schweizerische Medizinische Wochenschrift1979;109(20):737‐42. ">Friedli 1975</a>; <a href="./references#CD011138-bbs2-0009" title="LarssonO , MarinovichN , BarberK . Double‐blind trial of glycerol therapy in early stroke. The Lancet1976;1:832‐4. ">Larsson 1976</a>; <a href="./references#CD011138-bbs2-0012" title="YuY , KumanaCR , LauderIJ , CheungYK , ChanFL , KouM , et al. Treatment of acute cerebral hemorrhage with intravenous glycerol. A double‐blind, placebo‐controlled, randomized trial. Stroke1992;23(7):967‐71. ">Yu 1992</a>), dextran 40 (<a href="./references#CD011138-bbs2-0003" title="BorensteinN , RegevI , FlechaterS , StreiflerM , VardiJ . Dextran‐40 in nonhemorrhagic cerebrovascular accidents. Harefuah1981;100(10):455. ">Borenstein 1981</a>; <a href="./references#CD011138-bbs2-0006" title="GilroyJ , BarnhartM , MeyerJS . Treatment of acute stroke with Dextran 40. JAMA1969;210(2):293‐8. ">Gilroy 1969</a>; <a href="./references#CD011138-bbs2-0010" title="MatthewsWB , OxburyJM , GraingerKM , GreenhallRC . A blind controlled trial of dextran 40 in the treatment of ischaemic stroke. Brain1976;99:193‐206. ">Matthews 1976</a>), albumin (<a href="./references#CD011138-bbs2-0007" title="GinsbergMD , PaleschYY , MartinRH , HillMD , MoyCS , WaldmanBD , et al. The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. Stroke2011;42:119‐27. ">Ginsberg 2011</a>; <a href="./references#CD011138-bbs2-0008" title="GinsbergMD , PaleschYY , HillMD , MartinRH , MoyCS , BarsanWG , et al. High‐dose albumin treatment for acute ischaemic stroke (ALIAS) part 2: a randomised, double‐blind, phase 3, placebo‐controlled trial. The Lancet Neurology2013;12:1049‐58. ">Ginsberg 2013</a>); or isotonic (crystalloids): Ringer's lactate (<a href="./references#CD011138-bbs2-0001" title="AichnerFT , FazekasF , BraininM , PolzW , MamoliB , ZeilerK . Hypervolemic hemodilution in acute ischemic stroke. The Multicenter Austrian Hemodilution Stroke Trial (MAHST). Stroke1998;29:743‐9. ">Aichner 1998</a>), Hartmann's (<a href="./references#CD011138-bbs2-0003" title="BorensteinN , RegevI , FlechaterS , StreiflerM , VardiJ . Dextran‐40 in nonhemorrhagic cerebrovascular accidents. Harefuah1981;100(10):455. ">Borenstein 1981</a>), dextrose (5% or 10%) (<a href="./references#CD011138-bbs2-0005" title="FriedliW , ImbachP , Ghisleni‐SteineggerS , SchwarzC , MaireP . Treatment with 10% glycerin in acute ischaemic cerebral infarct. Double blind study. Schweizerische Medizinische Wochenschrift1979;109(20):737‐42. ">Friedli 1975</a>; <a href="./references#CD011138-bbs2-0009" title="LarssonO , MarinovichN , BarberK . Double‐blind trial of glycerol therapy in early stroke. The Lancet1976;1:832‐4. ">Larsson 1976</a>; <a href="./references#CD011138-bbs2-0010" title="MatthewsWB , OxburyJM , GraingerKM , GreenhallRC . A blind controlled trial of dextran 40 in the treatment of ischaemic stroke. Brain1976;99:193‐206. ">Matthews 1976</a>), dextrose saline mixtures (<a href="./references#CD011138-bbs2-0004" title="FawerR , JustafreJC , BergerJP , SchellingJL . Intravenous glycerol in cerebral infarction: a controlled 4 month trial. Stroke1978;9:484‐6. ">Fawer 1978</a>; <a href="./references#CD011138-bbs2-0006" title="GilroyJ , BarnhartM , MeyerJS . Treatment of acute stroke with Dextran 40. JAMA1969;210(2):293‐8. ">Gilroy 1969</a>), 0.9% saline (<a href="./references#CD011138-bbs2-0002" title="BayerAJ , PathyMSJ , NewcombeR . Double‐blind randomised trial of intravenous glycerol in acute stroke. The Lancet1987;1:405‐8. ">Bayer 1987</a>; <a href="./references#CD011138-bbs2-0007" title="GinsbergMD , PaleschYY , MartinRH , HillMD , MoyCS , WaldmanBD , et al. The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. Stroke2011;42:119‐27. ">Ginsberg 2011</a>; <a href="./references#CD011138-bbs2-0008" title="GinsbergMD , PaleschYY , HillMD , MartinRH , MoyCS , BarsanWG , et al. High‐dose albumin treatment for acute ischaemic stroke (ALIAS) part 2: a randomised, double‐blind, phase 3, placebo‐controlled trial. The Lancet Neurology2013;12:1049‐58. ">Ginsberg 2013</a>; <a href="./references#CD011138-bbs2-0011" title="RudolfJ . Hydroxyethyl starch for hypervolemic hemodilution in patients with acute ischemic stroke: a randomized, placebo‐controlled phase II safety study. Cerebrovascular Diseases2002;14(1):33‐41. ">Rudolf 2002</a>; <a href="./references#CD011138-bbs2-0012" title="YuY , KumanaCR , LauderIJ , CheungYK , ChanFL , KouM , et al. Treatment of acute cerebral hemorrhage with intravenous glycerol. A double‐blind, placebo‐controlled, randomized trial. Stroke1992;23(7):967‐71. ">Yu 1992</a>), relative to plasma. All 12 trials compared colloids versus crystalloids. Of the 12 trials, five compared 0.9% saline with another fluid type that tended to be colloids (for example albumin, glycerol, and hydroethyl starch). </p> <p>Ten studies reported their funding source: six studies were supported by national grants (from international research centres, institutes of health, or hospital research organisations) (<a href="./references#CD011138-bbs2-0002" title="BayerAJ , PathyMSJ , NewcombeR . Double‐blind randomised trial of intravenous glycerol in acute stroke. The Lancet1987;1:405‐8. ">Bayer 1987</a>; <a href="./references#CD011138-bbs2-0004" title="FawerR , JustafreJC , BergerJP , SchellingJL . Intravenous glycerol in cerebral infarction: a controlled 4 month trial. Stroke1978;9:484‐6. ">Fawer 1978</a>; <a href="./references#CD011138-bbs2-0006" title="GilroyJ , BarnhartM , MeyerJS . Treatment of acute stroke with Dextran 40. JAMA1969;210(2):293‐8. ">Gilroy 1969</a>; <a href="./references#CD011138-bbs2-0007" title="GinsbergMD , PaleschYY , MartinRH , HillMD , MoyCS , WaldmanBD , et al. The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. Stroke2011;42:119‐27. ">Ginsberg 2011</a>; <a href="./references#CD011138-bbs2-0008" title="GinsbergMD , PaleschYY , HillMD , MartinRH , MoyCS , BarsanWG , et al. High‐dose albumin treatment for acute ischaemic stroke (ALIAS) part 2: a randomised, double‐blind, phase 3, placebo‐controlled trial. The Lancet Neurology2013;12:1049‐58. ">Ginsberg 2013</a>; <a href="./references#CD011138-bbs2-0010" title="MatthewsWB , OxburyJM , GraingerKM , GreenhallRC . A blind controlled trial of dextran 40 in the treatment of ischaemic stroke. Brain1976;99:193‐206. ">Matthews 1976</a>); two studies were supported by the hospital where the study took place or university respectively (<a href="./references#CD011138-bbs2-0009" title="LarssonO , MarinovichN , BarberK . Double‐blind trial of glycerol therapy in early stroke. The Lancet1976;1:832‐4. ">Larsson 1976</a>; <a href="./references#CD011138-bbs2-0012" title="YuY , KumanaCR , LauderIJ , CheungYK , ChanFL , KouM , et al. Treatment of acute cerebral hemorrhage with intravenous glycerol. A double‐blind, placebo‐controlled, randomized trial. Stroke1992;23(7):967‐71. ">Yu 1992</a>); and two studies were supported by makers of intravenous fluid products (<a href="./references#CD011138-bbs2-0001" title="AichnerFT , FazekasF , BraininM , PolzW , MamoliB , ZeilerK . Hypervolemic hemodilution in acute ischemic stroke. The Multicenter Austrian Hemodilution Stroke Trial (MAHST). Stroke1998;29:743‐9. ">Aichner 1998</a>; <a href="./references#CD011138-bbs2-0011" title="RudolfJ . Hydroxyethyl starch for hypervolemic hemodilution in patients with acute ischemic stroke: a randomized, placebo‐controlled phase II safety study. Cerebrovascular Diseases2002;14(1):33‐41. ">Rudolf 2002</a>). </p> </section> <section id="CD011138-sec-0060"> <h4 class="title">Excluded studies</h4> <p>Of the 53 studies evaluated for inclusion in the review, we excluded 41 (see <a href="./references#CD011138-sec-0099" title="">Characteristics of excluded studies</a>). </p> <p>The reasons for exclusion were:</p> <p> <ol id="CD011138-list-0023"> <li> <p>results were not fully reported, and although we made contact with authors, we did not receive a reply (9/41); </p> </li> <li> <p>no disability outcome was reported (11/41);</p> </li> <li> <p>use of venesection (6/41);</p> </li> <li> <p>unclear if the design was randomised (6/41);</p> </li> <li> <p>outcomes not reported with absolute data (4/41); and</p> </li> <li> <p>data not extractable from summary/abstract available (2/41)</p> </li> <li> <p><a href="./references#CD011138-bbs2-0043" title="SpudisEV , de laTorreE , PikulaL . Management of completed strokes with dextran 40. A community hospital failure. Stroke1973;4(6):895‐7. ">Spudis 1973</a> did not report a control group (1/41); </p> </li> <li> <p><a href="./references#CD011138-bbs2-0044" title="StaedtU , SchlierfG , OsterP , MechtersheimerU , BaesslerG , SeufzerU . Hypervolemic hemodilution with 10% HES 200/0.5 and 10% Dextran 40 in patients with ischemic stroke. Cerebral Ischemia and Hemorheology. Springer, 1987:429‐35. ">Staedt 1987</a> compared two colloids, which did not fit our study comparison criteria (1/41); and </p> </li> <li> <p><a href="./references#CD011138-bbs2-0017" title="FreiA , CottierC , WunderlichP . Glycerol and dextran combined in the therapy of acute stroke. A placebo‐controlled, double‐blind trial with a planned interim analysis. Stroke1987;18(2):373‐9. ">Frei 1987</a> id not report results according to the randomized groups; hence raising ambiguity about the effect of the intervention (1/41). </p> </li> </ol> </p> </section> </section> <section id="CD011138-sec-0061"> <h3 class="title">Risk of bias in included studies</h3> <p>See <a href="#CD011138-fig-0002">Figure 2</a>; <a href="#CD011138-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD011138-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011138-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_n/nCD011138-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD011138-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011138-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_n/nCD011138-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD011138-sec-0062"> <h4 class="title">Allocation</h4> <section id="CD011138-sec-0063"> <h5 class="title">Random sequence generation</h5> <p>Of the 12 included trials, seven gave details of randomisation. These trials used a table of random numbers (1/7), series of envelopes (2/7), a stratified randomised block design (2/7), or coin‐based minimisation algorithm (2/7). The other five trials did not fully explain the randomisation process (<a href="./references#CD011138-bbs2-0002" title="BayerAJ , PathyMSJ , NewcombeR . Double‐blind randomised trial of intravenous glycerol in acute stroke. The Lancet1987;1:405‐8. ">Bayer 1987</a>; <a href="./references#CD011138-bbs2-0003" title="BorensteinN , RegevI , FlechaterS , StreiflerM , VardiJ . Dextran‐40 in nonhemorrhagic cerebrovascular accidents. Harefuah1981;100(10):455. ">Borenstein 1981</a>; <a href="./references#CD011138-bbs2-0005" title="FriedliW , ImbachP , Ghisleni‐SteineggerS , SchwarzC , MaireP . Treatment with 10% glycerin in acute ischaemic cerebral infarct. Double blind study. Schweizerische Medizinische Wochenschrift1979;109(20):737‐42. ">Friedli 1975</a>; <a href="./references#CD011138-bbs2-0009" title="LarssonO , MarinovichN , BarberK . Double‐blind trial of glycerol therapy in early stroke. The Lancet1976;1:832‐4. ">Larsson 1976</a>; <a href="./references#CD011138-bbs2-0011" title="RudolfJ . Hydroxyethyl starch for hypervolemic hemodilution in patients with acute ischemic stroke: a randomized, placebo‐controlled phase II safety study. Cerebrovascular Diseases2002;14(1):33‐41. ">Rudolf 2002</a>). </p> </section> <section id="CD011138-sec-0064"> <h5 class="title">Allocation sequence concealment</h5> <p>Five trials adequately concealed randomisation, and four did not (<a href="./references#CD011138-bbs2-0002" title="BayerAJ , PathyMSJ , NewcombeR . Double‐blind randomised trial of intravenous glycerol in acute stroke. The Lancet1987;1:405‐8. ">Bayer 1987</a>; <a href="./references#CD011138-bbs2-0004" title="FawerR , JustafreJC , BergerJP , SchellingJL . Intravenous glycerol in cerebral infarction: a controlled 4 month trial. Stroke1978;9:484‐6. ">Fawer 1978</a>; <a href="./references#CD011138-bbs2-0005" title="FriedliW , ImbachP , Ghisleni‐SteineggerS , SchwarzC , MaireP . Treatment with 10% glycerin in acute ischaemic cerebral infarct. Double blind study. Schweizerische Medizinische Wochenschrift1979;109(20):737‐42. ">Friedli 1975</a>; <a href="./references#CD011138-bbs2-0010" title="MatthewsWB , OxburyJM , GraingerKM , GreenhallRC . A blind controlled trial of dextran 40 in the treatment of ischaemic stroke. Brain1976;99:193‐206. ">Matthews 1976</a>). Three studies had an unclear risk, as although concealment was mentioned, information on how this was done was insufficient (<a href="./references#CD011138-bbs2-0003" title="BorensteinN , RegevI , FlechaterS , StreiflerM , VardiJ . Dextran‐40 in nonhemorrhagic cerebrovascular accidents. Harefuah1981;100(10):455. ">Borenstein 1981</a>; <a href="./references#CD011138-bbs2-0009" title="LarssonO , MarinovichN , BarberK . Double‐blind trial of glycerol therapy in early stroke. The Lancet1976;1:832‐4. ">Larsson 1976</a>; <a href="./references#CD011138-bbs2-0011" title="RudolfJ . Hydroxyethyl starch for hypervolemic hemodilution in patients with acute ischemic stroke: a randomized, placebo‐controlled phase II safety study. Cerebrovascular Diseases2002;14(1):33‐41. ">Rudolf 2002</a>). </p> </section> </section> <section id="CD011138-sec-0065"> <h4 class="title">Blinding</h4> <p>Of the 12 included studies, eight studies blinded participants and clinicians who measured outcome, two trials blinded clinicians who measured outcome but not participants (<a href="./references#CD011138-bbs2-0005" title="FriedliW , ImbachP , Ghisleni‐SteineggerS , SchwarzC , MaireP . Treatment with 10% glycerin in acute ischaemic cerebral infarct. Double blind study. Schweizerische Medizinische Wochenschrift1979;109(20):737‐42. ">Friedli 1975</a>; <a href="./references#CD011138-bbs2-0010" title="MatthewsWB , OxburyJM , GraingerKM , GreenhallRC . A blind controlled trial of dextran 40 in the treatment of ischaemic stroke. Brain1976;99:193‐206. ">Matthews 1976</a>), and two trials offered no information on blinding (<a href="./references#CD011138-bbs2-0006" title="GilroyJ , BarnhartM , MeyerJS . Treatment of acute stroke with Dextran 40. JAMA1969;210(2):293‐8. ">Gilroy 1969</a>; <a href="./references#CD011138-bbs2-0011" title="RudolfJ . Hydroxyethyl starch for hypervolemic hemodilution in patients with acute ischemic stroke: a randomized, placebo‐controlled phase II safety study. Cerebrovascular Diseases2002;14(1):33‐41. ">Rudolf 2002</a>). Although <a href="./references#CD011138-bbs2-0012" title="YuY , KumanaCR , LauderIJ , CheungYK , ChanFL , KouM , et al. Treatment of acute cerebral hemorrhage with intravenous glycerol. A double‐blind, placebo‐controlled, randomized trial. Stroke1992;23(7):967‐71. ">Yu 1992</a> was said to be a double‐blind study, this was not consistently justified throughout the study protocol. </p> </section> <section id="CD011138-sec-0066"> <h4 class="title">Incomplete outcome data</h4> <p>Six of the 12 included studies reported outcomes on all participants randomised. A further five did not report all outcomes in all randomised participants (<a href="./references#CD011138-bbs2-0001" title="AichnerFT , FazekasF , BraininM , PolzW , MamoliB , ZeilerK . Hypervolemic hemodilution in acute ischemic stroke. The Multicenter Austrian Hemodilution Stroke Trial (MAHST). Stroke1998;29:743‐9. ">Aichner 1998</a>; <a href="./references#CD011138-bbs2-0007" title="GinsbergMD , PaleschYY , MartinRH , HillMD , MoyCS , WaldmanBD , et al. The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. Stroke2011;42:119‐27. ">Ginsberg 2011</a>; <a href="./references#CD011138-bbs2-0008" title="GinsbergMD , PaleschYY , HillMD , MartinRH , MoyCS , BarsanWG , et al. High‐dose albumin treatment for acute ischaemic stroke (ALIAS) part 2: a randomised, double‐blind, phase 3, placebo‐controlled trial. The Lancet Neurology2013;12:1049‐58. ">Ginsberg 2013</a>; <a href="./references#CD011138-bbs2-0009" title="LarssonO , MarinovichN , BarberK . Double‐blind trial of glycerol therapy in early stroke. The Lancet1976;1:832‐4. ">Larsson 1976</a>; <a href="./references#CD011138-bbs2-0012" title="YuY , KumanaCR , LauderIJ , CheungYK , ChanFL , KouM , et al. Treatment of acute cerebral hemorrhage with intravenous glycerol. A double‐blind, placebo‐controlled, randomized trial. Stroke1992;23(7):967‐71. ">Yu 1992</a>). It was unclear how many participants were lost to follow‐up in <a href="./references#CD011138-bbs2-0011" title="RudolfJ . Hydroxyethyl starch for hypervolemic hemodilution in patients with acute ischemic stroke: a randomized, placebo‐controlled phase II safety study. Cerebrovascular Diseases2002;14(1):33‐41. ">Rudolf 2002</a>. </p> </section> <section id="CD011138-sec-0067"> <h4 class="title">Selective reporting</h4> <p>Although planned, ALIAS 1 did not report a long‐term disability outcome (<a href="./references#CD011138-bbs2-0007" title="GinsbergMD , PaleschYY , MartinRH , HillMD , MoyCS , WaldmanBD , et al. The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. Stroke2011;42:119‐27. ">Ginsberg 2011</a>). <a href="./references#CD011138-bbs2-0009" title="LarssonO , MarinovichN , BarberK . Double‐blind trial of glycerol therapy in early stroke. The Lancet1976;1:832‐4. ">Larsson 1976</a> did not report all final specified outcomes at follow‐up. <a href="./references#CD011138-bbs2-0008" title="GinsbergMD , PaleschYY , HillMD , MartinRH , MoyCS , BarsanWG , et al. High‐dose albumin treatment for acute ischaemic stroke (ALIAS) part 2: a randomised, double‐blind, phase 3, placebo‐controlled trial. The Lancet Neurology2013;12:1049‐58. ">Ginsberg 2013</a> and <a href="./references#CD011138-bbs2-0012" title="YuY , KumanaCR , LauderIJ , CheungYK , ChanFL , KouM , et al. Treatment of acute cerebral hemorrhage with intravenous glycerol. A double‐blind, placebo‐controlled, randomized trial. Stroke1992;23(7):967‐71. ">Yu 1992</a> both had unclear risks for selective outcome reporting biases. </p> </section> <section id="CD011138-sec-0068"> <h4 class="title">Other potential sources of bias</h4> <p>The ALIAS trials were halted prior to reaching their planned sample size (<a href="./references#CD011138-bbs2-0007" title="GinsbergMD , PaleschYY , MartinRH , HillMD , MoyCS , WaldmanBD , et al. The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. Stroke2011;42:119‐27. ">Ginsberg 2011</a>; <a href="./references#CD011138-bbs2-0008" title="GinsbergMD , PaleschYY , HillMD , MartinRH , MoyCS , BarsanWG , et al. High‐dose albumin treatment for acute ischaemic stroke (ALIAS) part 2: a randomised, double‐blind, phase 3, placebo‐controlled trial. The Lancet Neurology2013;12:1049‐58. ">Ginsberg 2013</a>). Truncated RCTs may systematically overestimate treatment effects for the outcome (<a href="./references#CD011138-bbs2-0057" title="BasslerD , BrielM , MontoriVM , LaneM , GlasziouP , ZhouQ , et al. Stopping randomized trials early for benefit and estimation of treatment effects: systematic review and meta‐regression analysis. JAMA2010;303(12):1180‐7. ">Bassler 2010</a>; <a href="./references#CD011138-bbs2-0071" title="HowardG , HessDC , HowardVJ . Wisdom and determination in the ongoing pursuit of the ever‐elusive neuroprotective agent. Stroke2011;42(6):1505‐6. ">Howard 2011</a>). In <a href="./references#CD011138-bbs2-0012" title="YuY , KumanaCR , LauderIJ , CheungYK , ChanFL , KouM , et al. Treatment of acute cerebral hemorrhage with intravenous glycerol. A double‐blind, placebo‐controlled, randomized trial. Stroke1992;23(7):967‐71. ">Yu 1992</a>, it was unclear if the same assessor followed up participants, which could account for observer variability. </p> </section> </section> <section id="CD011138-sec-0069"> <h3 class="title" id="CD011138-sec-0069">Effects of interventions</h3> <p>See: <a href="./full#CD011138-tbl-0001"><b>Summary of findings for the main comparison</b> Colloids versus crystalloids for improving functional outcome in people with acute stroke</a>; <a href="./full#CD011138-tbl-0002"><b>Summary of findings 2</b> 0.9% saline versus other fluid for improving functional outcome in people with acute stroke</a> </p> <p>The 12 studies recruited a total of 2351 people; most studies were small. The number of participants ranged from 27 to 841; the median was 103. </p> <section id="CD011138-sec-0070"> <h4 class="title">Effect of fluids</h4> <section id="CD011138-sec-0071"> <h5 class="title">Colloids versus crystalloids</h5> <p>Twelve studies (2351 participants) compared colloids with crystalloids and reported death, death or dependence, or secondary outcomes of pneumonia, cerebral oedema, or pulmonary oedema. </p> <p>We found no difference in the odds of death or dependence, or death, at three to 12 months between participants allocated to colloids compared with participants allocated to crystalloids, although the 95% CI did not exclude important harms or important benefits from either regimen (OR for death or dependence 0.97, 95% CI 0.79 to 1.21, I² = 58%, <a href="./references#CD011138-fig-0004" title="">Analysis 1.1</a>; OR for death 1.02, 95% CI 0.82 to 1.27, I² = 24%, <a href="./references#CD011138-fig-0005" title="">Analysis 1.2</a>). There was significant between‐trial heterogeneity in our summary estimates of the effect of colloids compared with crystalloids on death or dependence. For this reason, we graded the evidence as moderate quality for the outcome death, and as low quality for the outcome death or dependence due to study limitations and inconsistency for the outcome. </p> <p>Based on the two studies reporting the outcome pneumonia between participants allocated to colloids versus crystalloids, the confidence interval of the odds of this outcome did not exclude harms or benefits from either regimen (OR 0.58, 95% CI 0.17 to 2.01, I² = 0%, two studies, <a href="./references#CD011138-fig-0006" title="">Analysis 1.3</a>). The two studies reporting this outcome compared 10% hydroethyl starch with Ringer's lactate and glycerol with 0.9% saline (<a href="./references#CD011138-bbs2-0001" title="AichnerFT , FazekasF , BraininM , PolzW , MamoliB , ZeilerK . Hypervolemic hemodilution in acute ischemic stroke. The Multicenter Austrian Hemodilution Stroke Trial (MAHST). Stroke1998;29:743‐9. ">Aichner 1998</a>; <a href="./references#CD011138-bbs2-0012" title="YuY , KumanaCR , LauderIJ , CheungYK , ChanFL , KouM , et al. Treatment of acute cerebral hemorrhage with intravenous glycerol. A double‐blind, placebo‐controlled, randomized trial. Stroke1992;23(7):967‐71. ">Yu 1992</a>). </p> <p><a href="./references#CD011138-bbs2-0001" title="AichnerFT , FazekasF , BraininM , PolzW , MamoliB , ZeilerK . Hypervolemic hemodilution in acute ischemic stroke. The Multicenter Austrian Hemodilution Stroke Trial (MAHST). Stroke1998;29:743‐9. ">Aichner 1998</a> reported cerebral oedema. Based on this one study, the confidence interval of odds of cerebral oedema between participants allocated to colloids versus crystalloids did not exclude significant harms, or significant benefits from either regimen (OR 0.20, 95% CI 0.02 to 1.74, <a href="./references#CD011138-fig-0007" title="">Analysis 1.4</a>). </p> <p>The odds of pulmonary oedema were approximately doubled with colloids compared with crystalloids (OR 2.34, 95% CI 1.28 to 4.29, I² = 0%, three studies, <a href="./references#CD011138-fig-0008" title="">Analysis 1.5</a>) (<a href="./references#CD011138-bbs2-0001" title="AichnerFT , FazekasF , BraininM , PolzW , MamoliB , ZeilerK . Hypervolemic hemodilution in acute ischemic stroke. The Multicenter Austrian Hemodilution Stroke Trial (MAHST). Stroke1998;29:743‐9. ">Aichner 1998</a>; <a href="./references#CD011138-bbs2-0007" title="GinsbergMD , PaleschYY , MartinRH , HillMD , MoyCS , WaldmanBD , et al. The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. Stroke2011;42:119‐27. ">Ginsberg 2011</a>; <a href="./references#CD011138-bbs2-0011" title="RudolfJ . Hydroxyethyl starch for hypervolemic hemodilution in patients with acute ischemic stroke: a randomized, placebo‐controlled phase II safety study. Cerebrovascular Diseases2002;14(1):33‐41. ">Rudolf 2002</a>). The crystalloid comparators were Ringer's lactate in <a href="./references#CD011138-bbs2-0001" title="AichnerFT , FazekasF , BraininM , PolzW , MamoliB , ZeilerK . Hypervolemic hemodilution in acute ischemic stroke. The Multicenter Austrian Hemodilution Stroke Trial (MAHST). Stroke1998;29:743‐9. ">Aichner 1998</a> and 0.9% saline in <a href="./references#CD011138-bbs2-0007" title="GinsbergMD , PaleschYY , MartinRH , HillMD , MoyCS , WaldmanBD , et al. The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. Stroke2011;42:119‐27. ">Ginsberg 2011</a> and <a href="./references#CD011138-bbs2-0011" title="RudolfJ . Hydroxyethyl starch for hypervolemic hemodilution in patients with acute ischemic stroke: a randomized, placebo‐controlled phase II safety study. Cerebrovascular Diseases2002;14(1):33‐41. ">Rudolf 2002</a>. </p> <p>We downgraded the quality of evidence once for pneumonia (from high to moderate) and once for cerebral and pulmonary oedema (from moderate to low) due to study limitations. </p> <p>Only <a href="./references#CD011138-bbs2-0012" title="YuY , KumanaCR , LauderIJ , CheungYK , ChanFL , KouM , et al. Treatment of acute cerebral hemorrhage with intravenous glycerol. A double‐blind, placebo‐controlled, randomized trial. Stroke1992;23(7):967‐71. ">Yu 1992</a> reported the outcomes of death and pneumonia in people with haemorrhagic stroke. The estimates for participants with haemorrhagic stroke were similar to participants with ischaemic stroke, and the CIs were consistent with the estimates for studies of participants with ischaemic stroke. </p> <p>At the request of our editorial reviewers, we performed post‐hoc sensitivity analyses to compare the results of fixed‐effect meta‐analysis with random‐effects meta‐analyses. There were no important differences in the size or the statistical significance of our findings with this method of meta‐analysis. </p> </section> <section id="CD011138-sec-0072"> <h5 class="title">0.9% saline versus other fluids</h5> <p>A total of five studies with 1760 participants compared 0.9% saline with other fluid regimens. Outcomes reported were death, death or dependence, and secondary outcomes of pneumonia and pulmonary oedema. </p> <p>There was no significant difference in the odds of death or dependence for those randomised to 0.9% saline compared with those randomised to other fluids (OR 1.04, 95% CI 0.82 to 1.32, I² = 71%, three studies, <a href="./references#CD011138-fig-0009" title="">Analysis 2.1</a>) (<a href="./references#CD011138-bbs2-0002" title="BayerAJ , PathyMSJ , NewcombeR . Double‐blind randomised trial of intravenous glycerol in acute stroke. The Lancet1987;1:405‐8. ">Bayer 1987</a>; <a href="./references#CD011138-bbs2-0007" title="GinsbergMD , PaleschYY , MartinRH , HillMD , MoyCS , WaldmanBD , et al. The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. Stroke2011;42:119‐27. ">Ginsberg 2011</a>; <a href="./references#CD011138-bbs2-0011" title="RudolfJ . Hydroxyethyl starch for hypervolemic hemodilution in patients with acute ischemic stroke: a randomized, placebo‐controlled phase II safety study. Cerebrovascular Diseases2002;14(1):33‐41. ">Rudolf 2002</a>). There was no difference in the odds of death between participants treated with 0.9% saline versus participants treated with other fluids, although the CI did not exclude a beneficial effect or a smaller harmful effect (OR 0.87, 95% CI 0.67 to 1.12, I² = 53%, five studies, <a href="./references#CD011138-fig-0010" title="">Analysis 2.2</a>). We downgraded the quality of evidence to low for both these outcomes due to study limitations and inconsistency, with substantial heterogeneity. </p> <p><a href="./references#CD011138-bbs2-0012" title="YuY , KumanaCR , LauderIJ , CheungYK , ChanFL , KouM , et al. Treatment of acute cerebral hemorrhage with intravenous glycerol. A double‐blind, placebo‐controlled, randomized trial. Stroke1992;23(7):967‐71. ">Yu 1992</a> was the only study that reported pneumonia for this comparison: four participants developed pneumonia in the 0.9% saline group versus two in the other‐fluid group (OR 2.00, 95% CI 0.36 to 11.16, <a href="./references#CD011138-fig-0011" title="">Analysis 2.3</a>). <a href="./references#CD011138-bbs2-0007" title="GinsbergMD , PaleschYY , MartinRH , HillMD , MoyCS , WaldmanBD , et al. The albumin in acute stroke (ALIAS) multicenter clinical trial: safety analysis of part 1 and rationale and design of part 2. Stroke2011;42:119‐27. ">Ginsberg 2011</a> was the only study to report pulmonary oedema, with nine events in the saline group and 25 in the other‐fluid group (OR 0.32, 95% CI 0.14 to 0.69, <a href="./references#CD011138-fig-0012" title="">Analysis 2.4</a>), favouring 0.9% saline. </p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011138-sec-0073" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011138-sec-0073"></div> <section id="CD011138-sec-0074"> <h3 class="title" id="CD011138-sec-0074">Summary of main results</h3> <p>We found no compelling evidence that early fluid replacement with colloids rather than crystalloids led to a difference in the odds of death, or death or dependence, three to 12 months after stroke, although colloids did lead to a doubling in the odds of pulmonary oedema. The summary estimate was consistent with both a modest increase and a modest reduction in the odds of death, or death or dependence, with either regimen. </p> <p>We did not find any evidence to guide the best volume, duration, or route of administration of parenteral fluids in people with acute stroke. </p> </section> <section id="CD011138-sec-0075"> <h3 class="title" id="CD011138-sec-0075">Overall completeness and applicability of evidence</h3> <p>We have searched publicly available electronic databases up to and including the beginning of May 2015 comprehensively for trials of parenteral fluids in people with acute stroke. Due to limited resources we did not search the grey literature extensively, although we did search the Cochrane Stroke Group database of RCTs, which contains an up‐to‐date register of published and unpublished trials. Data from two trials that had completed recruitment but had not published results and one trial in progress were unavailable. It is therefore possible that we missed relevant studies. </p> <p>There was substantial statistical heterogeneity in the odds ratios for death and death or dependence with colloids and crystalloids between the trials. Potential clinical reasons for this heterogeneity are the different types of colloids in different trials; the substantial time from the earliest to the latest trials (from 1969 to 2013), and hence differences in brain scanning, widespread use of nasogastric fluids, and easily titratable fluid delivery systems; the different hospital settings of different trials; or chance. Our summary estimate, whilst the best available, should therefore be interpreted with caution. More data to guide the volume, duration, and mode of delivery of parenteral fluids would be useful for clinical practice. </p> <p>We did not find any evidence for renal impairment with different fluid types after stroke, and there was very little evidence for important clinical outcomes such as cerebral oedema. </p> </section> <section id="CD011138-sec-0076"> <h3 class="title" id="CD011138-sec-0076">Quality of the evidence</h3> <p>For assessments of the overall quality of evidence for each outcome that included pooled data for RCTs only, we graded evidence as moderate quality (for the primary outcome, death or dependence) and low quality for the rest of the outcome measures due to study limitations, indirectness of evidence, inconsistency, and imprecision. Inconsistency was the main reason for most of these downgradings, as evidenced by high heterogeneity values. Similarly, we graded evidence as low quality in our second comparison (0.9% saline versus other fluids) primarily due to risk of bias and inconsistency of results across the small number of included studies. As many trials were performed prior to the widespread adoption of Consolidated Standards of Reporting Trials (CONSORT) guidelines, randomisation and allocation concealment were inadequately described, particularly in the earlier studies. The modest heterogeneity across studies requires further research to determine the effects of fluids on death, or death or dependence. </p> </section> <section id="CD011138-sec-0077"> <h3 class="title" id="CD011138-sec-0077">Potential biases in the review process</h3> <p>Whilst we comprehensively searched the electronic databases literature, we may have missed some studies in the grey literature. We used the Cochrane Stroke Group's trials register, which does not include dissertations, and we did not handsearch non‐stroke related journals. </p> <p>Due to lack of resources for the review, the initial screening and data entry were performed by one, rather than two review authors. </p> <p>Prior to the review, we were unable to define thresholds of fluid volume, or the duration of fluid treatment that would divide studies into relevant comparison groups. Although we did not find any studies to answer questions about fluid volume or duration, it may arise in future that studies are available with different doses of an intervention (for example oxygen therapy, rehabilitation), and there is no generally agreed threshold. </p> </section> <section id="CD011138-sec-0078"> <h3 class="title" id="CD011138-sec-0078">Agreements and disagreements with other studies or reviews</h3> <p>Although there are numerous papers and trials on haemodilution after an acute ischaemic stroke, and discussions around hypervolaemic, isovolaemic and hypovolaemic haemodilution with the use of venesection or the combination of venesection and infusion of fluids (<a href="./references#CD011138-bbs2-0068" title="HerosR , KorosueK . Hemodilution for cerebral ischaemia. Stroke1989;20:423‐7. ">Heros 1989</a>; <a href="./references#CD011138-bbs2-0072" title="Italian Acute Stroke Study Group. Haemodilution in acute stroke: results of the Italian haemodilution trial. The Lancet1988;1:318‐21. ">IASS 1988</a>; <a href="./references#CD011138-bbs2-0075" title="KollerM , HaennyP , HessK , WenigerD , ZanggerP . Adjusted hypervolemic hemodilution in acute ischemic stroke. Stroke1990;21(10):1429‐34. ">Koller 1990</a>; <a href="./references#CD011138-bbs2-0079" title="MastH , MarxP . Neurological deterioration under isovolemic hemodilution with hydroxyethyl starch in acute cerebral ischemia. Stroke1991;22:955. ">Mast 1991</a>; <a href="./references#CD011138-bbs2-0088" title="Scandinavian Stroke Study Group. Multicenter trial of hemodilution in acute ischemic stroke I. Results in the total patient population. Stroke1987;18:691‐9. ">SSS 1987</a>), there have actually been few trials that have compared the use of fluid regimens without venesection. A Cochrane review concluded that haemodilution with or without venesection had no place in the routine treatment of people with acute stroke (<a href="./references#CD011138-bbs2-0059" title="ChangTS , JensenMB . Haemodilution for acute ischaemic stroke. Cochrane Database of Systematic Reviews2014, Issue 8. [DOI: 10.1002/14651858.CD000103.pub2] ">Chang 2014</a>). </p> <p>The most recent major review of parenteral fluids was guidance from the UK National Institute for Health and Care Excellence (<a href="./references#CD011138-bbs2-0081" title="NICE: National Institute for Health and Care Excellence. Intravenous fluid therapy in adults in hospital. http://www.nice.org.uk/guidance/index.jsp?action=byID&amp;o=143302013. ">NICE 2013</a>). The review commented on special circumstances for maintaining intravenous fluid management in people with stroke, although it found no evidence to support fluid prescription in people with stroke. The review planned to determine the best fluid type in hospitalised patients, although it found no randomised evidence on the superiority of any crystalloids solution over any other solution. Four small studies of surgical inpatients were found that compared fluid volume after abdominal surgery, but none that were relevant to medical inpatients or people with stroke. This review was therefore consistent with our own, although we have identified more studies comparing fluid types in people with stroke. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011138-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/urn:x-wiley:14651858:media:CD011138:CD011138-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_t/tCD011138-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD011138-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_n/nCD011138-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/full#CD011138-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_n/nCD011138-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011138-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/urn:x-wiley:14651858:media:CD011138:CD011138-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_t/tCD011138-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD011138-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_n/nCD011138-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/full#CD011138-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_n/nCD011138-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011138-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/urn:x-wiley:14651858:media:CD011138:CD011138-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_t/tCD011138-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD011138-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_n/nCD011138-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/full#CD011138-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_n/nCD011138-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011138-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/urn:x-wiley:14651858:media:CD011138:CD011138-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_t/tCD011138-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Colloids versus crystalloids, Outcome 1 Death or dependence." data-id="CD011138-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_n/nCD011138-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Colloids versus crystalloids, Outcome 1 Death or dependence.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/references#CD011138-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_n/nCD011138-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011138-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/urn:x-wiley:14651858:media:CD011138:CD011138-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_t/tCD011138-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Colloids versus crystalloids, Outcome 2 Death." data-id="CD011138-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_n/nCD011138-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Colloids versus crystalloids, Outcome 2 Death.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/references#CD011138-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_n/nCD011138-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011138-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/urn:x-wiley:14651858:media:CD011138:CD011138-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_t/tCD011138-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Colloids versus crystalloids, Outcome 3 Pneumonia." data-id="CD011138-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_n/nCD011138-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Colloids versus crystalloids, Outcome 3 Pneumonia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/references#CD011138-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_n/nCD011138-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011138-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/urn:x-wiley:14651858:media:CD011138:CD011138-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_t/tCD011138-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Colloids versus crystalloids, Outcome 4 Cerebral oedema." data-id="CD011138-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_n/nCD011138-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Colloids versus crystalloids, Outcome 4 Cerebral oedema.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/references#CD011138-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_n/nCD011138-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011138-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/urn:x-wiley:14651858:media:CD011138:CD011138-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_t/tCD011138-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Colloids versus crystalloids, Outcome 5 Pulmonary oedema." data-id="CD011138-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_n/nCD011138-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Colloids versus crystalloids, Outcome 5 Pulmonary oedema.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/references#CD011138-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_n/nCD011138-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011138-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/urn:x-wiley:14651858:media:CD011138:CD011138-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_t/tCD011138-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 0.9% saline versus other fluid, Outcome 1 Death or dependence." data-id="CD011138-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_n/nCD011138-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 0.9% saline versus other fluid, Outcome 1 Death or dependence.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/references#CD011138-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_n/nCD011138-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011138-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/urn:x-wiley:14651858:media:CD011138:CD011138-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_t/tCD011138-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 0.9% saline versus other fluid, Outcome 2 Death." data-id="CD011138-fig-0010" src="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_n/nCD011138-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 0.9% saline versus other fluid, Outcome 2 Death.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/references#CD011138-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_n/nCD011138-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011138-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/urn:x-wiley:14651858:media:CD011138:CD011138-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_t/tCD011138-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 0.9% saline versus other fluid, Outcome 3 Pneumonia." data-id="CD011138-fig-0011" src="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_n/nCD011138-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 0.9% saline versus other fluid, Outcome 3 Pneumonia.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/references#CD011138-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_n/nCD011138-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011138-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/urn:x-wiley:14651858:media:CD011138:CD011138-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_t/tCD011138-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 0.9% saline versus other fluid, Outcome 4 Pulmonary oedema." data-id="CD011138-fig-0012" src="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_n/nCD011138-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 0.9% saline versus other fluid, Outcome 4 Pulmonary oedema.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/references#CD011138-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/media/CDSR/CD011138/image_n/nCD011138-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011138-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Colloids versus crystalloids for improving functional outcome in people with acute stroke</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Colloids versus crystalloids for improving functional outcome in people with acute stroke</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with acute ischaemic or haemorrhagic stroke<br/> <b>Settings:</b> all trials were undertaken in a hospital setting in various parts of the world including USA, UK, Europe, Israel, Australia, and Hong Kong<br/> <b>Intervention:</b> colloids versus crystalloids </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Colloids versus crystalloids</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Death or dependence</b> <br/> Follow‐up: 3‐12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.97</b> <br/> (0.79 to 1.21) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1420<br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>589 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>581 per 1000</b> <br/> (531 to 634) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>639 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>632 per 1000</b> <br/> (583 to 682) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Death</b> <br/> Follow‐up: 3‐12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 1.02</b> <br/> (0.82 to 1.27) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>2351<br/> (12 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>202 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>206 per 1000</b> <br/> (172 to 244) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>219 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>222 per 1000</b> <br/> (187 to 263) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Pneumonia</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.58</b> <br/> (0.17 to 2.01) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>416<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>33 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>20 per 1000</b> <br/> (6 to 65) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>33 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>19 per 1000</b> <br/> (6 to 64) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Cerebral oedema</b> <br/> Follow‐up: median 3 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.20</b> <br/> (0.02 to 1.74) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>200<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>49 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>10 per 1000</b> <br/> (1 to 82) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>49 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>10 per 1000</b> <br/> (1 to 82) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Pulmonary oedema</b> <br/> Follow‐up: median 90 days </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 2.34</b> <br/> (1.28 to 4.29) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>730<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>45 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>99 per 1000</b> <br/> (57 to 168) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>49 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>108 per 1000</b> <br/> (62 to 181) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in the footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <b>CI:</b> Confidence interval; <b>OR:</b> Odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Downgraded due to study limitations and inconsistency with substantial heterogeneity<br/> <sup>2</sup> Substantial heterogeneity<br/> <sup>3</sup> The confidence interval did not exclude important benefits or harms<br/> <sup>4</sup> Based on two studies, study limitations acknowledged<br/> <sup>5</sup> Data from one study only, no comparisons<br/> <sup>6</sup> Based on three studies, OR above 2.0 </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Colloids versus crystalloids for improving functional outcome in people with acute stroke</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/full#CD011138-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011138-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">0.9% saline versus other fluid for improving functional outcome in people with acute stroke</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>0.9% saline versus other fluid for improving functional outcome in people with acute stroke</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with acute ischaemic or haemorrhagic stroke<br/> <b>Settings: a</b> ll trials were undertaken in a hospital setting in various parts of the world including USA, UK, Europe, Israel, and Hong Kong<br/> <b>Intervention:</b> 0.9% saline versus other fluid </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Control</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> 0.9% saline versus other fluid</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Death or dependence</b> <br/> Follow‐up: 3‐12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 1.04</b> <br/> (0.82 to 1.32) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1120<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>553 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>563 per 1000</b> <br/> (503 to 620) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>540 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>550 per 1000</b> <br/> (490 to 608) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Death</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.87</b> <br/> (0.67 to 1.12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>1760<br/> (5 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>210 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>188 per 1000</b> <br/> (151 to 229) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>208 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>186 per 1000</b> <br/> (150 to 227) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Pneumonia</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 2.00</b> <br/> (0.36 to 11.16) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>216<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>19 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>37 per 1000</b> <br/> (7 to 175) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>19 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>37 per 1000</b> <br/> (7 to 178) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Pulmonary oedema</b> <br/> Follow‐up: mean 48 hours </p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Study population</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>OR 0.32</b> <br/> (0.14 to 0.69) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>424<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>121 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>41 per 1000</b> <br/> (19 to 87) </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Moderate</b> </p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>121 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>41 per 1000</b> <br/> (19 to 87) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in the footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI)<br/> <b>CI:</b> Confidence interval; <b>OR:</b> Odds ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate<br/> <b>Very low quality:</b> We are very uncertain about the estimate </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Study limitations acknowledged<br/> <sup>2</sup> Substantial heterogeneity<br/> <sup>3</sup> Unclear of blinding<br/> <sup>4</sup> Sample size lower than calculated<br/> <sup>5</sup> Incomplete reporting<br/> <sup>6</sup> Early termination of study </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">0.9% saline versus other fluid for improving functional outcome in people with acute stroke</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/full#CD011138-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011138-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Colloids versus crystalloids</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Death or dependence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1420</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.79, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2351</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.82, 1.27]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pneumonia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>416</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.17, 2.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Cerebral oedema <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.02, 1.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pulmonary oedema <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>730</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.34 [1.28, 4.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Colloids versus crystalloids</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/references#CD011138-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011138-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">0.9% saline versus other fluid</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Death or dependence <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.82, 1.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Death <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1760</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.67, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pneumonia <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>216</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [0.36, 11.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pulmonary oedema <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>424</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.14, 0.69]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">0.9% saline versus other fluid</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011138.pub2/references#CD011138-tbl-0004">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011138.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD011138-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011138-note-0009">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD011138-note-0002">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD011138-note-0001">Hrvatski</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011138\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011138\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011138\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011138\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011138\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011138\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011138\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011138\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011138\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011138\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011138\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011138\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011138\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011138\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011138\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011138\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011138\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011138\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=mV7VuqgF&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011138.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011138.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011138.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011138.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011138.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740729106822"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011138.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740729106826"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011138.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ed4cce94ff56f',t:'MTc0MDcyOTEwNy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 